assay_description,canonical_smiles,document_chembl_id,relation,standard_relation,standard_type,standard_units,standard_value,type,units,value,SMILES,year
Inhibition of Mer,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,CHEMBL1139387,=,=,IC50,nM,1.0,IC50,nM,1.0,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1,2009.0
Inhibition of Mer,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL1140952,=,=,IC50,nM,14.0,IC50,nM,14.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2009.0
Binding affinity to MERTK at 10 uM by Ambit binding assay relative to control,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL1140952,=,=,Activity,%,10.0,Activity,%,10.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2009.0
Binding affinity to Mer at 10 uM by Ambit binding assay relative to control,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL1140952,<,<,Activity,%,1.0,Activity,%,1.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2009.0
Inhibition of MERTK at 3 uM,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,CHEMBL1142492,<,<,Inhibition,%,10.0,INH,%,10.0,CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1,2008.0
Binding affinity to human MER at 10 uM relative to control,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,CHEMBL1151712,=,=,Activity,%,24.9,Activity,%,24.9,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,2008.0
Binding affinity to human MER at 10 uM relative to control,NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1,CHEMBL1151712,,,Activity,,,Activity,,,NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,CHEMBL1151712,,,Activity,,,Activity,,,N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2,2008.0
Binding affinity to human MER at 10 uM relative to control,N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1,CHEMBL1151712,=,=,Activity,%,13.4,Activity,%,13.4,N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,CHEMBL1151712,=,=,Activity,%,7.8,Activity,%,7.8,O=C1Nc2ccccc2/C1=C/c1ccc[nH]1,2008.0
Binding affinity to human MER at 10 uM relative to control,CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2,CHEMBL1151712,,,Activity,,,Activity,,,CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2,2008.0
Binding affinity to human MER at 10 uM relative to control,CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C,CHEMBL1151712,,,Activity,,,Activity,,,CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C,2008.0
Binding affinity to human MER at 10 uM relative to control,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,CHEMBL1151712,=,=,Activity,%,7.9,Activity,%,7.9,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,2008.0
Binding affinity to human MER at 10 uM relative to control,Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1,CHEMBL1151712,,,Activity,,,Activity,,,Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1,2008.0
Binding affinity to human MER at 10 uM relative to control,NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1,CHEMBL1151712,,,Activity,,,Activity,,,NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1,CHEMBL1151712,=,=,Activity,%,0.6,Activity,%,0.6,Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1,2008.0
Binding affinity to human MER at 10 uM relative to control,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,CHEMBL1151712,,,Activity,,,Activity,,,Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,CHEMBL1151712,,,Activity,,,Activity,,,Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,CHEMBL1151712,,,Activity,,,Activity,,,Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1,CHEMBL1151712,=,=,Activity,%,0.3,Activity,%,0.3,CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1,2008.0
Binding affinity to human MER at 10 uM relative to control,O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1,CHEMBL1151712,,,Activity,,,Activity,,,O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1,2008.0
Binding affinity to human MER at 10 uM relative to control,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,CHEMBL1151712,,,Activity,,,Activity,,,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,2008.0
Inhibition of Mer assessed as residual activity at 20 uM,O=S(=O)(c1cccc2nonc12)n1ccc2ncc(-c3cnn(C4CCNCC4)c3)cc21,CHEMBL1152913,=,=,Activity,%,19.0,Activity,%,19.0,O=S(=O)(c1cccc2nonc12)n1ccc2ncc(-c3cnn(C4CCNCC4)c3)cc21,2009.0
Binding constant for MERTK kinase domain,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL1150977,=,=,Kd,nM,870.0,Kd,nM,870.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2008.0
Binding constant for MERTK kinase domain,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,2008.0
Binding constant for MERTK kinase domain,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL1150977,=,=,Kd,nM,370.0,Kd,nM,370.0,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,2008.0
Binding constant for MERTK kinase domain,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,2008.0
Binding constant for MERTK kinase domain,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,CHEMBL1150977,=,=,Kd,nM,3700.0,Kd,nM,3700.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,2008.0
Binding constant for MERTK kinase domain,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,2008.0
Binding constant for MERTK kinase domain,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,CHEMBL1150977,=,=,Kd,nM,1800.0,Kd,nM,1800.0,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,2008.0
Binding constant for MERTK kinase domain,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,2008.0
Binding constant for MERTK kinase domain,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,2008.0
Binding constant for MERTK kinase domain,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,2008.0
Binding constant for MERTK kinase domain,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,2008.0
Binding constant for MERTK kinase domain,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2008.0
Binding constant for MERTK kinase domain,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,CHEMBL1150977,=,=,Kd,nM,1300.0,Kd,nM,1300.0,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,2008.0
Binding constant for MERTK kinase domain,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2008.0
Binding constant for MERTK kinase domain,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,CHEMBL1150977,=,=,Kd,nM,6800.0,Kd,nM,6800.0,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,2008.0
Binding constant for MERTK kinase domain,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,2008.0
Binding constant for MERTK kinase domain,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2008.0
Binding constant for MERTK kinase domain,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,CHEMBL1150977,=,=,Kd,nM,3300.0,Kd,nM,3300.0,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,2008.0
Binding constant for MERTK kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2008.0
Binding constant for MERTK kinase domain,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CHEMBL1150977,=,=,Kd,nM,2800.0,Kd,nM,2800.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,2008.0
Binding constant for MERTK kinase domain,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2008.0
Binding constant for MERTK kinase domain,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,2008.0
Binding constant for MERTK kinase domain,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2008.0
Binding constant for MERTK kinase domain,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,CHEMBL1150977,=,=,Kd,nM,730.0,Kd,nM,730.0,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,2008.0
Binding constant for MERTK kinase domain,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2008.0
Binding constant for MERTK kinase domain,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1150977,=,=,Kd,nM,2900.0,Kd,nM,2900.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2008.0
Binding constant for MERTK kinase domain,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,2008.0
Binding constant for MERTK kinase domain,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,2008.0
Binding constant for MERTK kinase domain,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2008.0
Binding constant for MERTK kinase domain,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2008.0
Binding constant for MERTK kinase domain,NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1,2008.0
Binding constant for MERTK kinase domain,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1150977,=,=,Kd,nM,3600.0,Kd,nM,3600.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2008.0
Binding constant for MERTK kinase domain,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1150977,=,=,Kd,nM,6.4,Kd,nM,6.4,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2008.0
Binding constant for MERTK kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,CHEMBL1150977,=,=,Kd,nM,66.0,Kd,nM,66.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,2008.0
Binding constant for MERTK kinase domain,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1150977,=,=,Kd,nM,26.0,Kd,nM,26.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2008.0
Binding constant for MERTK kinase domain,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,CHEMBL1150977,=,=,Kd,nM,1700.0,Kd,nM,1700.0,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,2008.0
Binding constant for MERTK kinase domain,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,CHEMBL1150977,>,>,Kd,nM,10000.0,Kd,uM,10.0,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,2008.0
Binding constant for MERTK kinase domain,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL1150977,=,=,Kd,nM,1400.0,Kd,nM,1400.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2008.0
Inhibition of MERTK assessed as enzyme activity at 1 uM relative to untreated control,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,CHEMBL1155237,=,=,Activity,%,99.0,Activity,%,99.0,Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl,2009.0
Inhibition of MER at 1 uM,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1,CHEMBL1154622,=,=,Inhibition,%,9.0,INH,%,9.0,Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1,2009.0
Residual activity of MERTK at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,19.0,Residual activity,%,19.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of MERTK at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,2.0,Residual activity,%,2.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of MERTK at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,75.0,Residual activity,%,75.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of MERTK at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,16.0,Residual activity,%,16.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of MERTK at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,3.0,Residual activity,%,3.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Residual activity of MERTK at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,57.0,Residual activity,%,57.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of MERTK at 1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,11.0,Residual activity,%,11.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of MERTK at 10 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,CHEMBL1152560,=,=,Residual activity,%,1.0,Residual activity,%,1.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1,2009.0
Residual activity of MERTK at 0.1 uM by microplate scintillation counting,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,CHEMBL1152560,=,=,Residual activity,%,68.0,Residual activity,%,68.0,COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1,2009.0
Inhibition of MER at 5 uM,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,CHEMBL1154316,=,=,Inhibition,%,5.0,INH,%,5.0,O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O,2009.0
Inhibition of MERTK at 10 uM,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1,CHEMBL1154277,<,<,Inhibition,%,50.0,INH,%,50.0,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1,2009.0
Inhibition of MERTK at 10 uM,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1,CHEMBL1154277,<,<,Inhibition,%,50.0,INH,%,50.0,Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1,2009.0
Inhibition of MERTK at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1,2010.0
Inhibition of MERTK at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1,2010.0
Inhibition of MERTK at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1,2010.0
Inhibition of MERTK at 1 uM,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1,2010.0
Inhibition of MERTK at 1 uM,O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1,2010.0
Inhibition of MERTK at 1 uM,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1,2010.0
Inhibition of MERTK at 1 uM,COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1,2010.0
Inhibition of MERTK at 1 uM,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1,2010.0
Inhibition of MERTK at 1 uM,FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21,2010.0
Inhibition of MERTK at 1 uM,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,CHEMBL1165965,<,<,Inhibition,%,50.0,INH,%,50.0,CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1,2010.0
Inhibition of MERTK at 10 uM,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,CHEMBL1177794,=,=,Inhibition,%,5.2,INH,%,5.2,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1,2010.0
Inhibition of MERTK at 10 uM,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,CHEMBL1177794,=,=,Inhibition,%,0.5,INH,%,0.5,CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1,2010.0
Inhibition of MERTK at 1 uM by radiometric method,CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2,CHEMBL1212904,<,<,Inhibition,%,10.0,INH,%,10.0,CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2,2010.0
Inhibition of MERTK at 1 uM by radiometric method,CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2,CHEMBL1212904,<,<,Inhibition,%,10.0,INH,%,10.0,CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2,2010.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,CHEMBL1240340,=,=,Inhibition,%,19.0,INH,%,19.0,CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21,2008.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,CHEMBL1240340,=,=,Inhibition,%,12.0,INH,%,12.0,Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1,2008.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,CHEMBL1240340,=,=,Inhibition,%,21.0,INH,%,21.0,CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21,2008.0
Binding affinity to MERTK,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,CHEMBL1240346,=,=,Kd,nM,32.0,Kd,nM,32.0,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,2009.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC,CHEMBL1240340,=,=,Inhibition,%,5.0,INH,%,5.0,COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC,2008.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,CHEMBL1240340,=,=,Inhibition,%,11.0,INH,%,11.0,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,2008.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,CHEMBL1240340,=,=,Inhibition,%,10.0,INH,%,10.0,CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21,2008.0
Inhibition of MERTK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,CHEMBL1240340,=,=,Inhibition,%,17.0,INH,%,17.0,Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21,2008.0
Binding affinity to MERTK,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2009.0
Binding affinity to MERTK,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1240346,=,=,Kd,nM,2900.0,Kd,nM,2900.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2009.0
Binding affinity to MERTK,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1240346,=,=,Kd,nM,26.0,Kd,nM,26.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2009.0
Binding affinity to MERTK,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1240346,=,=,Kd,nM,3600.0,Kd,nM,3600.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2009.0
Binding affinity to MERTK,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,2009.0
Binding affinity to MERTK,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,CHEMBL1240346,>,>,Kd,nM,10000.0,Kd,uM,10.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,2009.0
Inhibition of MERTK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,CHEMBL1250448,=,=,Inhibition,%,5.0,INH,%,5.0,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12,2009.0
Inhibition of MERTK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,CHEMBL1250448,=,=,Inhibition,%,16.0,INH,%,16.0,COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1,2009.0
Inhibition of MERTK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,CHEMBL1250448,=,=,Inhibition,%,17.0,INH,%,17.0,O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1,2009.0
Inhibition of human Mer at 10 uM after 60 mins by TR-FRET assay,S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1,CHEMBL1641539,=,=,Inhibition,%,107.0,INH,%,107.0,S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1,2011.0
Inhibition of MERTK at 1 uM,CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21,CHEMBL1641548,=,=,Inhibition,%,98.0,INH,%,98.0,CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21,2011.0
Inhibition of human Mer,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,CHEMBL1800066,=,=,IC50,nM,24.0,IC50,nM,24.0,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1,2011.0
Activity of MERTK kinase at 1 uM,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,CHEMBL1821651,=,=,Activity,%,91.0,Activity,%,91.0,CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1,2011.0
Inhibition of recombinant MER,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,CHEMBL1833940,>,>,IC50,nM,10000.0,IC50,uM,10.0,CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O,2011.0
Binding constant for MERTK kinase domain,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,CHEMBL1908390,=,=,Kd,nM,2600.0,Kd,nM,2600.0,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,2011.0
Binding constant for MERTK kinase domain,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12,2011.0
Binding constant for MERTK kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2011.0
Binding constant for MERTK kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,CHEMBL1908390,=,=,Kd,nM,1300.0,Kd,nM,1300.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,2011.0
Binding constant for MERTK kinase domain,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL1908390,=,=,Kd,nM,26.0,Kd,nM,26.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2011.0
Binding constant for MERTK kinase domain,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21,2011.0
Binding constant for MERTK kinase domain,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,CHEMBL1908390,=,=,Kd,nM,3.6,Kd,nM,3.6,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2011.0
Binding constant for MERTK kinase domain,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1,2011.0
Binding constant for MERTK kinase domain,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2011.0
Binding constant for MERTK kinase domain,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,CHEMBL1908390,=,=,Kd,nM,3100.0,Kd,nM,3100.0,CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1,2011.0
Binding constant for MERTK kinase domain,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2011.0
Binding constant for MERTK kinase domain,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,CHEMBL1908390,=,=,Kd,nM,86.0,Kd,nM,86.0,CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl,2011.0
Binding constant for MERTK kinase domain,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,CHEMBL1908390,=,=,Kd,nM,19.0,Kd,nM,19.0,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2011.0
Binding constant for MERTK kinase domain,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,CHEMBL1908390,=,=,Kd,nM,8.5,Kd,nM,8.5,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1,2011.0
Binding constant for MERTK kinase domain,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,CHEMBL1908390,=,=,Kd,nM,980.0,Kd,nM,980.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2011.0
Binding constant for MERTK kinase domain,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1908390,=,=,Kd,nM,2900.0,Kd,nM,2900.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2011.0
Binding constant for MERTK kinase domain,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,2011.0
Binding constant for MERTK kinase domain,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,2011.0
Binding constant for MERTK kinase domain,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,CHEMBL1908390,=,=,Kd,nM,460.0,Kd,nM,460.0,COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1,2011.0
Binding constant for MERTK kinase domain,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,2011.0
Binding constant for MERTK kinase domain,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,CHEMBL1908390,=,=,Kd,nM,820.0,Kd,nM,820.0,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,2011.0
Binding constant for MERTK kinase domain,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,CHEMBL1908390,=,=,Kd,nM,3700.0,Kd,nM,3700.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1,2011.0
Binding constant for MERTK kinase domain,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,CHEMBL1908390,=,=,Kd,nM,0.27,Kd,nM,0.27,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1,2011.0
Binding constant for MERTK kinase domain,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,CHEMBL1908390,=,=,Kd,nM,750.0,Kd,nM,750.0,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1,2011.0
Binding constant for MERTK kinase domain,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,CHEMBL1908390,=,=,Kd,nM,4700.0,Kd,nM,4700.0,CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21,2011.0
Binding constant for MERTK kinase domain,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL1908390,=,=,Kd,nM,1400.0,Kd,nM,1400.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2011.0
Binding constant for MERTK kinase domain,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12,2011.0
Binding constant for MERTK kinase domain,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,CHEMBL1908390,=,=,Kd,nM,6800.0,Kd,nM,6800.0,CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1,2011.0
Binding constant for MERTK kinase domain,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1,2011.0
Binding constant for MERTK kinase domain,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1,2011.0
Binding constant for MERTK kinase domain,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,CHEMBL1908390,=,=,Kd,nM,1700.0,Kd,nM,1700.0,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,2011.0
Binding constant for MERTK kinase domain,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1,2011.0
Binding constant for MERTK kinase domain,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1,2011.0
Binding constant for MERTK kinase domain,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1,2011.0
Binding constant for MERTK kinase domain,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21,2011.0
Binding constant for MERTK kinase domain,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,CHEMBL1908390,=,=,Kd,nM,170.0,Kd,nM,170.0,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,2011.0
Binding constant for MERTK kinase domain,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl,2011.0
Binding constant for MERTK kinase domain,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,CHEMBL1908390,=,=,Kd,nM,870.0,Kd,nM,870.0,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1,2011.0
Binding constant for MERTK kinase domain,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,2011.0
Binding constant for MERTK kinase domain,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1,2011.0
Binding constant for MERTK kinase domain,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1,2011.0
Binding constant for MERTK kinase domain,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N,2011.0
Binding constant for MERTK kinase domain,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1,2011.0
Binding constant for MERTK kinase domain,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,2011.0
Binding constant for MERTK kinase domain,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,2011.0
Binding constant for MERTK kinase domain,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C,2011.0
Binding constant for MERTK kinase domain,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,CHEMBL1908390,=,=,Kd,nM,3200.0,Kd,nM,3200.0,CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1,2011.0
Binding constant for MERTK kinase domain,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,CHEMBL1908390,=,=,Kd,nM,32.0,Kd,nM,32.0,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O,2011.0
Binding constant for MERTK kinase domain,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,CHEMBL1908390,=,=,Kd,nM,2700.0,Kd,nM,2700.0,CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12,2011.0
Binding constant for MERTK kinase domain,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2011.0
Binding constant for MERTK kinase domain,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,2011.0
Binding constant for MERTK kinase domain,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,CHEMBL1908390,=,=,Kd,nM,1800.0,Kd,nM,1800.0,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1,2011.0
Binding constant for MERTK kinase domain,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,CHEMBL1908390,=,=,Kd,nM,4600.0,Kd,nM,4600.0,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,2011.0
Binding constant for MERTK kinase domain,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,CHEMBL1908390,=,=,Kd,nM,3500.0,Kd,nM,3500.0,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1,2011.0
Binding constant for MERTK kinase domain,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,2011.0
Binding constant for MERTK kinase domain,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,CHEMBL1908390,=,=,Kd,nM,370.0,Kd,nM,370.0,CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1,2011.0
Binding constant for MERTK kinase domain,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21,2011.0
Binding constant for MERTK kinase domain,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,CHEMBL1908390,=,=,Kd,nM,730.0,Kd,nM,730.0,O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1,2011.0
Binding constant for MERTK kinase domain,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,CHEMBL1908390,=,=,Kd,nM,110.0,Kd,nM,110.0,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl,2011.0
Binding constant for MERTK kinase domain,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl,2011.0
Binding constant for MERTK kinase domain,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21,2011.0
Binding constant for MERTK kinase domain,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2011.0
Binding constant for MERTK kinase domain,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL1908390,=,=,Kd,nM,3600.0,Kd,nM,3600.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2011.0
Binding constant for MERTK kinase domain,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1,2011.0
Binding constant for MERTK kinase domain,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2011.0
Binding constant for MERTK kinase domain,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,CHEMBL1908390,=,=,Kd,nM,3300.0,Kd,nM,3300.0,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,2011.0
Binding constant for MERTK kinase domain,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL1908390,=,=,Kd,nM,6.4,Kd,nM,6.4,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2011.0
Binding constant for MERTK kinase domain,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,2011.0
Binding constant for MERTK kinase domain,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl,2011.0
Binding constant for MERTK kinase domain,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,CHEMBL1908390,=,=,Kd,nM,400.0,Kd,nM,400.0,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,2011.0
Binding constant for MERTK kinase domain,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,CHEMBL1908390,>,>,Kd,nM,10000.0,Kd,nM,10000.0,CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1,2011.0
Binding constant for MERTK kinase domain,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,CHEMBL1908390,=,=,Kd,nM,66.0,Kd,nM,66.0,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1,2011.0
Inhibition of human recombinant MER at 0.5 uM by radiometric filter-binding assay,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,CHEMBL1914433,=,=,Inhibition,%,62.0,INH,%,62.0,Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12,2011.0
Inhibition of MERTK relative to control,Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,CHEMBL1914368,=,=,Inhibition,%,4.0,INH,%,4.0,Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12,2011.0
Inhibition of Mer,O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21,CHEMBL1933021,=,=,IC50,nM,6930.0,IC50,uM,6.93,O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21,2012.0
Inhibition of Mer,O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21,CHEMBL1933021,=,=,IC50,nM,2440.0,IC50,uM,2.44,O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21,2012.0
Inhibition of Mer,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1,CHEMBL1933021,=,=,IC50,nM,2340.0,IC50,uM,2.34,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1,2012.0
Inhibition of Mer,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1,CHEMBL1933021,=,=,IC50,nM,970.0,IC50,uM,0.97,C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1,2012.0
Inhibition of MERTK at 1 uM,CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl,CHEMBL1938300,=,=,Inhibition,%,100.0,INH,%,100.0,CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl,2011.0
Inhibition of MERTK at 1 uM,CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl,CHEMBL1938300,=,=,Inhibition,%,99.0,INH,%,99.0,CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl,2011.0
Inhibition of MER at 10 uM,COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1,CHEMBL2010722,=,=,Inhibition,%,35.0,INH,%,35.0,COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1,2012.0
Inhibition of Mer kinase,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL2021829,=,=,IC50,nM,14.0,IC50,nM,14.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2011.0
Inhibition of Mer kinase,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL2021829,=,=,IC50,nM,11300.0,IC50,uM,11.3,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2011.0
Inhibition of MER at 200 nM,CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1,CHEMBL2021829,>,>,Inhibition,%,80.0,INH,%,80.0,CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1,2011.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(C(C)C)nn(C[C@H]3CC[C@H](O)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,2400.0,IC50,uM,2.4,CNc1ncc2c(C(C)C)nn(C[C@H]3CC[C@H](O)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(C(C)C)nn(C[C@@H]3CCCN3)c2n1,CHEMBL2034931,=,=,IC50,nM,28000.0,IC50,uM,28.0,CNc1ncc2c(C(C)C)nn(C[C@@H]3CCCN3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(C(C)C)nn(CC3CCCNC3)c2n1,CHEMBL2034931,=,=,IC50,nM,7000.0,IC50,uM,7.0,CNc1ncc2c(C(C)C)nn(CC3CCCNC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(C(C)C)nn(CC3CCNCC3)c2n1,CHEMBL2034931,=,=,IC50,nM,9600.0,IC50,uM,9.6,CNc1ncc2c(C(C)C)nn(CC3CCNCC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,C=C(C)c1nn(C[C@H]2CC[C@H](O)CC2)c2nc(NC)ncc12,CHEMBL2034931,=,=,IC50,nM,860.0,IC50,uM,0.86,C=C(C)c1nn(C[C@H]2CC[C@H](O)CC2)c2nc(NC)ncc12,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](O)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,210.0,IC50,uM,0.21,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](O)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](O)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,200.0,IC50,uM,0.2,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](O)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,56.0,IC50,uM,0.056,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,180.0,IC50,uM,0.18,CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,25.0,IC50,uM,0.025,CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3cccc(OC)c3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,120.0,IC50,uM,0.12,CNc1ncc2c(-c3cccc(OC)c3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccccc3OC)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,1400.0,IC50,uM,1.4,CNc1ncc2c(-c3ccccc3OC)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(C(F)(F)F)cc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,170.0,IC50,uM,0.17,CNc1ncc2c(-c3ccc(C(F)(F)F)cc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(-c4ccccc4)cc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,56.0,IC50,uM,0.056,CNc1ncc2c(-c3ccc(-c4ccccc4)cc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3cccnc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,530.0,IC50,uM,0.53,CNc1ncc2c(-c3cccnc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(F)nc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,400.0,IC50,uM,0.4,CNc1ncc2c(-c3ccc(F)nc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,64.0,IC50,uM,0.064,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,18.0,IC50,uM,0.018,CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CN(C)c1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,2800.0,IC50,uM,2.8,CN(C)c1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,13.0,IC50,uM,0.013,CCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,5.8,IC50,uM,0.0058,CCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,14.0,IC50,uM,0.014,CCCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CC(C)Nc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,74.0,IC50,uM,0.074,CC(C)Nc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NC4CCC4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,62.0,IC50,uM,0.062,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NC4CCC4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,COCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,140.0,IC50,uM,0.14,COCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCN4CCOCC4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,4500.0,IC50,uM,4.5,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCN4CCOCC4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,8.2,IC50,uM,0.0082,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,COc1ccc(CNc2ncc3c(-c4ccccc4)nn(CC4CCC(N)CC4)c3n2)cc1,CHEMBL2034931,=,=,IC50,nM,10.0,IC50,uM,0.01,COc1ccc(CNc2ncc3c(-c4ccccc4)nn(CC4CCC(N)CC4)c3n2)cc1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,13.0,IC50,uM,0.013,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,10.0,IC50,uM,0.01,NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,1.8,IC50,nM,1.8,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)nc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,0.76,IC50,nM,0.76,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)nc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,0.25,IC50,nM,0.25,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,0.15,IC50,nM,0.15,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,2.9,IC50,nM,2.9,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,N[C@H]1CC[C@H](Cn2nc(-c3ccc(F)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,IC50,nM,3.0,IC50,nM,3.0,N[C@H]1CC[C@H](Cn2nc(-c3ccc(F)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer expressed in Escherichia coli BL21 (DE3) cells using EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL2034931,=,=,IC50,nM,11000.0,IC50,uM,11.0,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,Ki,nM,2.7,Ki,nM,2.7,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)nc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,Ki,nM,1.4,Ki,nM,1.4,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)nc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,Ki,nM,0.73,Ki,nM,0.73,CCCCNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,Ki,nM,0.56,Ki,nM,0.56,N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,Ki,nM,4.3,Ki,nM,4.3,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,N[C@H]1CC[C@H](Cn2nc(-c3ccc(F)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,CHEMBL2034931,=,=,Ki,nM,2.0,Ki,nM,2.0,N[C@H]1CC[C@H](Cn2nc(-c3ccc(F)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1,2012.0
Inhibition of Mer autophosphorylation in human 697 cells pretreated for 1 hr before addition of phosphatase inhibitor measured by Western blot analysis,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2034931,=,=,IC50,nM,141.0,IC50,nM,141.0,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2012.0
Inhibition of Mer,C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,CHEMBL2069216,>,>,IC50,nM,10000.0,IC50,uM,10.0,C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2012.0
Inhibition of Mer,N#Cc1ccc(Nc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1,CHEMBL2086237,=,=,IC50,nM,2200.0,IC50,uM,2.2,N#Cc1ccc(Nc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1,2012.0
Inhibition of Mer,N#Cc1ccc(Oc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1,CHEMBL2086237,=,=,IC50,nM,2400.0,IC50,uM,2.4,N#Cc1ccc(Oc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1,2012.0
Inhibition of Mer,COc1ccc(Oc2nc(Cl)ccc2[N+](=O)[O-])cc1,CHEMBL2086237,=,=,IC50,nM,3000.0,IC50,uM,3.0,COc1ccc(Oc2nc(Cl)ccc2[N+](=O)[O-])cc1,2012.0
Inhibition of Mer at 1 uM,CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,CHEMBL2151019,=,=,Inhibition,%,4.7,INH,%,4.7,CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1,2012.0
Inhibition of human MER assessed as residual enzyme activity at 1 uM by Ambit kinome assay,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,CHEMBL2169770,=,=,Activity,%,1.0,Activity,%,1.0,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,2012.0
Inhibition of human MER assessed as residual enzyme activity at 1 uM by Ambit kinome assay,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,CHEMBL2169770,=,=,Activity,%,1.3,Activity,%,1.3,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,2012.0
Binding affinity to human MER by Ambit titration assay,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,CHEMBL2169770,=,=,Kd,nM,72.0,Kd,nM,72.0,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,2012.0
Binding affinity to human MER by Ambit titration assay,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,CHEMBL2169770,=,=,Kd,nM,18.0,Kd,nM,18.0,CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1,2012.0
Inhibition of c-MER,Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21,CHEMBL2169840,=,=,IC50,nM,474.0,IC50,nM,474.0,Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21,2012.0
Inhibition of MERTK assessed as residual activity at 10 uM relative to control,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,CHEMBL2203081,=,=,Activity,%,83.0,Activity,%,83.0,O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1,2012.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,CHEMBL2218924,=,=,Residual Activity,%,116.0,Residual Activity,%,116.0,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,85.0,Residual Activity,%,85.0,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,CHEMBL2218924,=,=,Residual Activity,%,78.0,Residual Activity,%,78.0,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2c1cnn2-c1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,Nc1ncnc2c1cnn2-c1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,22.0,Residual Activity,%,22.0,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,CHEMBL2218924,=,=,Residual Activity,%,103.0,Residual Activity,%,103.0,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,CHEMBL2218924,=,=,Residual Activity,%,79.0,Residual Activity,%,79.0,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,CHEMBL2218924,=,=,Residual Activity,%,75.0,Residual Activity,%,75.0,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,CHEMBL2218924,=,=,Residual Activity,%,80.0,Residual Activity,%,80.0,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,CHEMBL2218924,=,=,Residual Activity,%,16.0,Residual Activity,%,16.0,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,CHEMBL2218924,=,=,Residual Activity,%,113.0,Residual Activity,%,113.0,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,CHEMBL2218924,=,=,Residual Activity,%,102.0,Residual Activity,%,102.0,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,CHEMBL2218924,=,=,Residual Activity,%,29.0,Residual Activity,%,29.0,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,CHEMBL2218924,=,=,Residual Activity,%,109.0,Residual Activity,%,109.0,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,CHEMBL2218924,=,=,Residual Activity,%,106.0,Residual Activity,%,106.0,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL2218924,=,=,Residual Activity,%,119.0,Residual Activity,%,119.0,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL2218924,=,=,Residual Activity,%,84.0,Residual Activity,%,84.0,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,CHEMBL2218924,=,=,Residual Activity,%,47.0,Residual Activity,%,47.0,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,69.0,Residual Activity,%,69.0,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,97.0,Residual Activity,%,97.0,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,7.0,Residual Activity,%,7.0,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,112.0,Residual Activity,%,112.0,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,CHEMBL2218924,=,=,Residual Activity,%,68.0,Residual Activity,%,68.0,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(=O)c1ccc(N2CCOCC2)cc1O,CHEMBL2218924,=,=,Residual Activity,%,115.0,Residual Activity,%,115.0,CC(=O)c1ccc(N2CCOCC2)cc1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,CHEMBL2218924,=,=,Residual Activity,%,46.0,Residual Activity,%,46.0,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,CHEMBL2218924,=,=,Residual Activity,%,8.0,Residual Activity,%,8.0,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,14.0,Residual Activity,%,14.0,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc2c(-c3ccncc3)c[nH]c2c1,CHEMBL2218924,=,=,Residual Activity,%,100.0,Residual Activity,%,100.0,c1ccc2c(-c3ccncc3)c[nH]c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(C=C(C#N)C#N)cc1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,COc1ccc(C=C(C#N)C#N)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,CHEMBL2218924,=,=,Residual Activity,%,4.0,Residual Activity,%,4.0,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1c2ccccc2-c2nc3nnnn3nc21,CHEMBL2218924,=,=,Residual Activity,%,124.0,Residual Activity,%,124.0,O=C1c2ccccc2-c2nc3nnnn3nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,CHEMBL2218924,=,=,Residual Activity,%,81.0,Residual Activity,%,81.0,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,CHEMBL2218924,=,=,Residual Activity,%,102.0,Residual Activity,%,102.0,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,CHEMBL2218924,=,=,Residual Activity,%,6.0,Residual Activity,%,6.0,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,CHEMBL2218924,=,=,Residual Activity,%,79.0,Residual Activity,%,79.0,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,111.0,Residual Activity,%,111.0,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,106.0,Residual Activity,%,106.0,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,CHEMBL2218924,=,=,Residual Activity,%,103.0,Residual Activity,%,103.0,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,8.0,Residual Activity,%,8.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,CHEMBL2218924,=,=,Residual Activity,%,109.0,Residual Activity,%,109.0,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,CHEMBL2218924,=,=,Residual Activity,%,113.0,Residual Activity,%,113.0,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,CHEMBL2218924,=,=,Residual Activity,%,51.0,Residual Activity,%,51.0,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,CHEMBL2218924,=,=,Residual Activity,%,111.0,Residual Activity,%,111.0,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,53.0,Residual Activity,%,53.0,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc2ncc(-c3ccccc3)nc2cc1C,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,Cc1cc2ncc(-c3ccccc3)nc2cc1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,CHEMBL2218924,=,=,Residual Activity,%,72.0,Residual Activity,%,72.0,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,60.0,Residual Activity,%,60.0,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,64.0,Residual Activity,%,64.0,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,CHEMBL2218924,=,=,Residual Activity,%,81.0,Residual Activity,%,81.0,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,CHEMBL2218924,=,=,Residual Activity,%,7.0,Residual Activity,%,7.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncc(-c3ccccc3)nc2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,COc1cc2ncc(-c3ccccc3)nc2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,3.0,Residual Activity,%,3.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CHEMBL2218924,=,=,Residual Activity,%,36.0,Residual Activity,%,36.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,CHEMBL2218924,=,=,Residual Activity,%,87.0,Residual Activity,%,87.0,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,12.0,Residual Activity,%,12.0,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,CHEMBL2218924,=,=,Residual Activity,%,102.0,Residual Activity,%,102.0,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,117.0,Residual Activity,%,117.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,CHEMBL2218924,=,=,Residual Activity,%,99.0,Residual Activity,%,99.0,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,-2.0,Residual Activity,%,-2.0,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,CHEMBL2218924,=,=,Residual Activity,%,99.0,Residual Activity,%,99.0,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,CHEMBL2218924,=,=,Residual Activity,%,86.0,Residual Activity,%,86.0,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,CHEMBL2218924,=,=,Residual Activity,%,19.0,Residual Activity,%,19.0,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,100.0,Residual Activity,%,100.0,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,CHEMBL2218924,=,=,Residual Activity,%,37.0,Residual Activity,%,37.0,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,2.0,Residual Activity,%,2.0,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,CHEMBL2218924,=,=,Residual Activity,%,34.0,Residual Activity,%,34.0,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,CHEMBL2218924,=,=,Residual Activity,%,100.0,Residual Activity,%,100.0,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,CHEMBL2218924,=,=,Residual Activity,%,78.0,Residual Activity,%,78.0,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,CHEMBL2218924,=,=,Residual Activity,%,99.0,Residual Activity,%,99.0,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,84.0,Residual Activity,%,84.0,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,77.0,Residual Activity,%,77.0,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1sc(=O)n(Cc2ccccc2)c1=O,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,Cn1sc(=O)n(Cc2ccccc2)c1=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,CHEMBL2218924,=,=,Residual Activity,%,54.0,Residual Activity,%,54.0,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,CHEMBL2218924,=,=,Residual Activity,%,67.0,Residual Activity,%,67.0,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,CHEMBL2218924,=,=,Residual Activity,%,73.0,Residual Activity,%,73.0,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,CHEMBL2218924,=,=,Residual Activity,%,8.0,Residual Activity,%,8.0,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL2218924,=,=,Residual Activity,%,54.0,Residual Activity,%,54.0,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,CHEMBL2218924,=,=,Residual Activity,%,69.0,Residual Activity,%,69.0,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,CHEMBL2218924,=,=,Residual Activity,%,26.0,Residual Activity,%,26.0,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,CHEMBL2218924,=,=,Residual Activity,%,100.0,Residual Activity,%,100.0,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,CHEMBL2218924,=,=,Residual Activity,%,68.0,Residual Activity,%,68.0,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,CHEMBL2218924,=,=,Residual Activity,%,-1.0,Residual Activity,%,-1.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,CHEMBL2218924,=,=,Residual Activity,%,90.0,Residual Activity,%,90.0,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1c2ccccc2c2c3c(cccc13)N=N2,CHEMBL2218924,=,=,Residual Activity,%,22.0,Residual Activity,%,22.0,Oc1c2ccccc2c2c3c(cccc13)N=N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,90.0,Residual Activity,%,90.0,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,CHEMBL2218924,=,=,Residual Activity,%,81.0,Residual Activity,%,81.0,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,CHEMBL2218924,=,=,Residual Activity,%,22.0,Residual Activity,%,22.0,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1n[nH]c2nc3ccccc3nc12,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,Nc1n[nH]c2nc3ccccc3nc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,CHEMBL2218924,=,=,Residual Activity,%,15.0,Residual Activity,%,15.0,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,CHEMBL2218924,=,=,Residual Activity,%,26.0,Residual Activity,%,26.0,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,CHEMBL2218924,=,=,Residual Activity,%,53.0,Residual Activity,%,53.0,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,CHEMBL2218924,=,=,Residual Activity,%,85.0,Residual Activity,%,85.0,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,CHEMBL2218924,=,=,Residual Activity,%,80.0,Residual Activity,%,80.0,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,CHEMBL2218924,=,=,Residual Activity,%,33.0,Residual Activity,%,33.0,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,103.0,Residual Activity,%,103.0,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,CHEMBL2218924,=,=,Residual Activity,%,39.0,Residual Activity,%,39.0,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,CHEMBL2218924,=,=,Residual Activity,%,82.0,Residual Activity,%,82.0,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,CHEMBL2218924,=,=,Residual Activity,%,91.0,Residual Activity,%,91.0,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,64.0,Residual Activity,%,64.0,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,CHEMBL2218924,=,=,Residual Activity,%,89.0,Residual Activity,%,89.0,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,CHEMBL2218924,=,=,Residual Activity,%,109.0,Residual Activity,%,109.0,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,CHEMBL2218924,=,=,Residual Activity,%,90.0,Residual Activity,%,90.0,CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,33.0,Residual Activity,%,33.0,O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,CHEMBL2218924,=,=,Residual Activity,%,74.0,Residual Activity,%,74.0,O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,CHEMBL2218924,=,=,Residual Activity,%,84.0,Residual Activity,%,84.0,CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2c1cnn2-c1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,Nc1ncnc2c1cnn2-c1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,16.0,Residual Activity,%,16.0,Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,51.0,Residual Activity,%,51.0,COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,CHEMBL2218924,=,=,Residual Activity,%,41.0,Residual Activity,%,41.0,Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,CHEMBL2218924,=,=,Residual Activity,%,58.0,Residual Activity,%,58.0,Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,CHEMBL2218924,=,=,Residual Activity,%,65.0,Residual Activity,%,65.0,O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,CHEMBL2218924,=,=,Residual Activity,%,86.0,Residual Activity,%,86.0,CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,CHEMBL2218924,=,=,Residual Activity,%,83.0,Residual Activity,%,83.0,CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,CHEMBL2218924,=,=,Residual Activity,%,26.0,Residual Activity,%,26.0,NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,CHEMBL2218924,=,=,Residual Activity,%,3.0,Residual Activity,%,3.0,CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,CHEMBL2218924,=,=,Residual Activity,%,48.0,Residual Activity,%,48.0,CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,CHEMBL2218924,=,=,Residual Activity,%,86.0,Residual Activity,%,86.0,COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,CHEMBL2218924,=,=,Residual Activity,%,42.0,Residual Activity,%,42.0,CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,CHEMBL2218924,=,=,Residual Activity,%,81.0,Residual Activity,%,81.0,CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,CHEMBL2218924,=,=,Residual Activity,%,99.0,Residual Activity,%,99.0,O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,CHEMBL2218924,=,=,Residual Activity,%,97.0,Residual Activity,%,97.0,CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,CHEMBL2218924,=,=,Residual Activity,%,31.0,Residual Activity,%,31.0,CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,CHEMBL2218924,=,=,Residual Activity,%,7.0,Residual Activity,%,7.0,O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,16.0,Residual Activity,%,16.0,COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,60.0,Residual Activity,%,60.0,COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,51.0,Residual Activity,%,51.0,O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,CHEMBL2218924,=,=,Residual Activity,%,85.0,Residual Activity,%,85.0,c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,4.0,Residual Activity,%,4.0,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,51.0,Residual Activity,%,51.0,O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,CHEMBL2218924,=,=,Residual Activity,%,83.0,Residual Activity,%,83.0,O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,CHEMBL2218924,=,=,Residual Activity,%,97.0,Residual Activity,%,97.0,COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,91.0,Residual Activity,%,91.0,CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,CHEMBL2218924,=,=,Residual Activity,%,55.0,Residual Activity,%,55.0,COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,CHEMBL2218924,=,=,Residual Activity,%,97.0,Residual Activity,%,97.0,Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,CHEMBL2218924,=,=,Residual Activity,%,45.0,Residual Activity,%,45.0,O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,CHEMBL2218924,=,=,Residual Activity,%,62.0,Residual Activity,%,62.0,CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(=O)c1ccc(N2CCOCC2)cc1O,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,CC(=O)c1ccc(N2CCOCC2)cc1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,CHEMBL2218924,=,=,Residual Activity,%,29.0,Residual Activity,%,29.0,Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,4.0,Residual Activity,%,4.0,COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc2c(-c3ccncc3)c[nH]c2c1,CHEMBL2218924,=,=,Residual Activity,%,73.0,Residual Activity,%,73.0,c1ccc2c(-c3ccncc3)c[nH]c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(C=C(C#N)C#N)cc1,CHEMBL2218924,=,=,Residual Activity,%,99.0,Residual Activity,%,99.0,COc1ccc(C=C(C#N)C#N)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,CHEMBL2218924,=,=,Residual Activity,%,2.0,Residual Activity,%,2.0,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1c2ccccc2-c2nc3nnnn3nc21,CHEMBL2218924,=,=,Residual Activity,%,103.0,Residual Activity,%,103.0,O=C1c2ccccc2-c2nc3nnnn3nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,CHEMBL2218924,=,=,Residual Activity,%,10.0,Residual Activity,%,10.0,COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,CHEMBL2218924,=,=,Residual Activity,%,52.0,Residual Activity,%,52.0,Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,CHEMBL2218924,=,=,Residual Activity,%,2.0,Residual Activity,%,2.0,O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,CHEMBL2218924,=,=,Residual Activity,%,21.0,Residual Activity,%,21.0,Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,CHEMBL2218924,=,=,Residual Activity,%,100.0,Residual Activity,%,100.0,COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,59.0,Residual Activity,%,59.0,COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,88.0,Residual Activity,%,88.0,O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,CHEMBL2218924,=,=,Residual Activity,%,70.0,Residual Activity,%,70.0,c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,CHEMBL2218924,=,=,Residual Activity,%,86.0,Residual Activity,%,86.0,O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,CHEMBL2218924,=,=,Residual Activity,%,58.0,Residual Activity,%,58.0,O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,6.0,Residual Activity,%,6.0,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,CHEMBL2218924,=,=,Residual Activity,%,89.0,Residual Activity,%,89.0,N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,CHEMBL2218924,=,=,Residual Activity,%,85.0,Residual Activity,%,85.0,O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,CHEMBL2218924,=,=,Residual Activity,%,89.0,Residual Activity,%,89.0,NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,CHEMBL2218924,=,=,Residual Activity,%,36.0,Residual Activity,%,36.0,CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,CO[C@H]1[C@@H](OC)C[C@H](C)[C@@H](OC)C2=CC(=O)C=C(NC(=O)/C(C)=C/C=C/[C@H](OC)[C@@H](OC(N)=O)/C(C)=C/[C@@H]1C)C2=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,CHEMBL2218924,=,=,Residual Activity,%,87.0,Residual Activity,%,87.0,O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,CHEMBL2218924,=,=,Residual Activity,%,60.0,Residual Activity,%,60.0,O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,38.0,Residual Activity,%,38.0,COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc2ncc(-c3ccccc3)nc2cc1C,CHEMBL2218924,=,=,Residual Activity,%,90.0,Residual Activity,%,90.0,Cc1cc2ncc(-c3ccccc3)nc2cc1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,CHEMBL2218924,=,=,Residual Activity,%,70.0,Residual Activity,%,70.0,O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,11.0,Residual Activity,%,11.0,CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,49.0,Residual Activity,%,49.0,COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,CHEMBL2218924,=,=,Residual Activity,%,17.0,Residual Activity,%,17.0,c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,CHEMBL2218924,=,=,Residual Activity,%,0.0,Residual Activity,%,0.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc2ncc(-c3ccccc3)nc2cc1OC,CHEMBL2218924,=,=,Residual Activity,%,62.0,Residual Activity,%,62.0,COc1cc2ncc(-c3ccccc3)nc2cc1OC,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,CHEMBL2218924,=,=,Residual Activity,%,68.0,Residual Activity,%,68.0,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,13.0,Residual Activity,%,13.0,CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,CHEMBL2218924,=,=,Residual Activity,%,83.0,Residual Activity,%,83.0,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,CHEMBL2218924,=,=,Residual Activity,%,79.0,Residual Activity,%,79.0,CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,CHEMBL2218924,=,=,Residual Activity,%,89.0,Residual Activity,%,89.0,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,-3.0,Residual Activity,%,-3.0,O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,CHEMBL2218924,=,=,Residual Activity,%,85.0,Residual Activity,%,85.0,COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,CHEMBL2218924,=,=,Residual Activity,%,57.0,Residual Activity,%,57.0,Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,CHEMBL2218924,=,=,Residual Activity,%,1.0,Residual Activity,%,1.0,Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,CHEMBL2218924,=,=,Residual Activity,%,114.0,Residual Activity,%,114.0,Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,CHEMBL2218924,=,=,Residual Activity,%,77.0,Residual Activity,%,77.0,O=S(=O)(c1cccc2cnccc12)N1CCCNCC1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,CHEMBL2218924,=,=,Residual Activity,%,108.0,Residual Activity,%,108.0,Cc1ccc(S(=O)(=O)/C=C/C#N)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,CHEMBL2218924,=,=,Residual Activity,%,110.0,Residual Activity,%,110.0,Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,CHEMBL2218924,=,=,Residual Activity,%,105.0,Residual Activity,%,105.0,Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,CHEMBL2218924,=,=,Residual Activity,%,21.0,Residual Activity,%,21.0,O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL2218924,=,=,Residual Activity,%,0.0,Residual Activity,%,0.0,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,CHEMBL2218924,=,=,Residual Activity,%,101.0,Residual Activity,%,101.0,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,CHEMBL2218924,=,=,Residual Activity,%,11.0,Residual Activity,%,11.0,O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,CHEMBL2218924,=,=,Residual Activity,%,82.0,Residual Activity,%,82.0,CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,CHEMBL2218924,=,=,Residual Activity,%,87.0,Residual Activity,%,87.0,CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,CHEMBL2218924,=,=,Residual Activity,%,97.0,Residual Activity,%,97.0,O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,CHEMBL2218924,=,=,Residual Activity,%,28.0,Residual Activity,%,28.0,O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,107.0,Residual Activity,%,107.0,O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,CHEMBL2218924,=,=,Residual Activity,%,88.0,Residual Activity,%,88.0,Cc1nc(-c2ccccc2)c(-c2ccncc2)o1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,33.0,Residual Activity,%,33.0,N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,CHEMBL2218924,=,=,Residual Activity,%,21.0,Residual Activity,%,21.0,O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1sc(=O)n(Cc2ccccc2)c1=O,CHEMBL2218924,=,=,Residual Activity,%,98.0,Residual Activity,%,98.0,Cn1sc(=O)n(Cc2ccccc2)c1=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,CHEMBL2218924,=,=,Residual Activity,%,9.0,Residual Activity,%,9.0,NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,CHEMBL2218924,=,=,Residual Activity,%,83.0,Residual Activity,%,83.0,COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,CHEMBL2218924,=,=,Residual Activity,%,24.0,Residual Activity,%,24.0,Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,CHEMBL2218924,=,=,Residual Activity,%,71.0,Residual Activity,%,71.0,CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,CHEMBL2218924,=,=,Residual Activity,%,-1.0,Residual Activity,%,-1.0,CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL2218924,=,=,Residual Activity,%,10.0,Residual Activity,%,10.0,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,CHEMBL2218924,=,=,Residual Activity,%,48.0,Residual Activity,%,48.0,Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,CHEMBL2218924,=,=,Residual Activity,%,-1.0,Residual Activity,%,-1.0,O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,CHEMBL2218924,=,=,Residual Activity,%,83.0,Residual Activity,%,83.0,N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,CHEMBL2218924,=,=,Residual Activity,%,0.0,Residual Activity,%,0.0,CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,CHEMBL2218924,=,=,Residual Activity,%,90.0,Residual Activity,%,90.0,Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,CHEMBL2218924,=,=,Residual Activity,%,80.0,Residual Activity,%,80.0,CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,CHEMBL2218924,=,=,Residual Activity,%,-1.0,Residual Activity,%,-1.0,Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,CHEMBL2218924,=,=,Residual Activity,%,60.0,Residual Activity,%,60.0,COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,CHEMBL2218924,=,=,Residual Activity,%,93.0,Residual Activity,%,93.0,COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1c2ccccc2c2c3c(cccc13)N=N2,CHEMBL2218924,=,=,Residual Activity,%,9.0,Residual Activity,%,9.0,Oc1c2ccccc2c2c3c(cccc13)N=N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,CHEMBL2218924,=,=,Residual Activity,%,92.0,Residual Activity,%,92.0,O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,CHEMBL2218924,=,=,Residual Activity,%,35.0,Residual Activity,%,35.0,Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,CHEMBL2218924,=,=,Residual Activity,%,2.0,Residual Activity,%,2.0,CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1n[nH]c2nc3ccccc3nc12,CHEMBL2218924,=,=,Residual Activity,%,73.0,Residual Activity,%,73.0,Nc1n[nH]c2nc3ccccc3nc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,CHEMBL2218924,=,=,Residual Activity,%,0.0,Residual Activity,%,0.0,CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,CHEMBL2218924,=,=,Residual Activity,%,4.0,Residual Activity,%,4.0,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,CHEMBL2218924,=,=,Residual Activity,%,21.0,Residual Activity,%,21.0,Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,CHEMBL2218924,=,=,Residual Activity,%,25.0,Residual Activity,%,25.0,O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,CHEMBL2218924,=,=,Residual Activity,%,28.0,Residual Activity,%,28.0,O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,CHEMBL2218924,=,=,Residual Activity,%,3.0,Residual Activity,%,3.0,c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,103.0,Residual Activity,%,103.0,NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,CHEMBL2218924,=,=,Residual Activity,%,75.0,Residual Activity,%,75.0,CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,CHEMBL2218924,=,=,Residual Activity,%,6.0,Residual Activity,%,6.0,CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,CHEMBL2218924,=,=,Residual Activity,%,69.0,Residual Activity,%,69.0,N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,CHEMBL2218924,=,=,Residual Activity,%,58.0,Residual Activity,%,58.0,Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,CHEMBL2218924,=,=,Residual Activity,%,95.0,Residual Activity,%,95.0,CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,CHEMBL2218924,=,=,Residual Activity,%,11.0,Residual Activity,%,11.0,COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,CHEMBL2218924,=,=,Residual Activity,%,94.0,Residual Activity,%,94.0,O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,CHEMBL2218924,=,=,Residual Activity,%,106.0,Residual Activity,%,106.0,N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,CHEMBL2218924,=,=,Residual Activity,%,86.0,Residual Activity,%,86.0,O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,CHEMBL2218924,=,=,Residual Activity,%,62.0,Residual Activity,%,62.0,Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,CHEMBL2218924,=,=,Residual Activity,%,96.0,Residual Activity,%,96.0,Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1,2013.0
"Millipore: Percentage of residual kinase activity of MERTK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl",N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,CHEMBL2218924,=,=,Residual Activity,%,104.0,Residual Activity,%,104.0,N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1,2013.0
Inhibition of Mer (unknown origin),O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,CHEMBL2311468,=,=,IC50,nM,775.0,IC50,uM,0.775,O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,2013.0
Inhibition of Mer (unknown origin),O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,CHEMBL2311468,=,=,IC50,nM,1920.0,IC50,uM,1.92,O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1,2013.0
Inhibition of Mer (unknown origin),COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,CHEMBL2311468,=,=,IC50,nM,4680.0,IC50,uM,4.68,COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1,2013.0
Inhibition of Mer (unknown origin),COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC,CHEMBL2311468,=,=,IC50,nM,126.0,IC50,uM,0.126,COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC,2013.0
Inhibition of MER (unknown origin) relative to control,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,CHEMBL2321765,=,=,Inhibition,%,60.0,INH,%,60.0,Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1,2013.0
Inhibition of MER (unknown origin),Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F,CHEMBL2331117,>,>,IC50,nM,10000.0,IC50,nM,10000.0,Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F,2013.0
Binding affinity to MER (unknown origin) after 1 hr,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Kd,nM,260.0,Kd,nM,260.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) after 1 hr,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Kd,nM,42.0,Kd,nM,42.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) after 1 hr,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Kd,nM,190.0,Kd,nM,190.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL2346606,=,=,Activity,%,99.0,Activity,%,99.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL2346606,=,=,Activity,%,100.0,Activity,%,100.0,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,16.0,Activity,%,16.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,16.0,Activity,%,16.0,O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,4.0,Activity,%,4.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,30.0,Activity,%,30.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,CHEMBL2346606,=,=,Activity,%,17.0,Activity,%,17.0,COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,59.0,Activity,%,59.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,66.0,Activity,%,66.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,55.0,Activity,%,55.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,81.0,Activity,%,81.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,15.0,Activity,%,15.0,Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,CHEMBL2346606,=,=,Activity,%,6.0,Activity,%,6.0,COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,24.0,Activity,%,24.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,99.0,Activity,%,99.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,99.0,Activity,%,99.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,97.0,Activity,%,97.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 75 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,40.0,Activity,%,40.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL2346606,=,=,Activity,%,59.0,Activity,%,59.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,CHEMBL2346606,=,=,Activity,%,99.6,Activity,%,99.6,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,8.0,Activity,%,8.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,8.0,Activity,%,8.0,O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,CHEMBL2346606,=,=,Activity,%,11.0,Activity,%,11.0,COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,15.0,Activity,%,15.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,12.0,Activity,%,12.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,25.0,Activity,%,25.0,Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,36.0,Activity,%,36.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,33.0,Activity,%,33.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,39.0,Activity,%,39.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,75.0,Activity,%,75.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br,CHEMBL2346606,=,=,Activity,%,15.0,Activity,%,15.0,Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,28.0,Activity,%,28.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,84.0,Activity,%,84.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL2346606,=,=,Activity,%,99.0,Activity,%,99.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,CHEMBL2346606,=,=,Activity,%,89.0,Activity,%,89.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O,2013.0
Binding affinity to MER (unknown origin) at 1 uM after 1 hr relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,CHEMBL2346606,=,=,Activity,%,0.0,Activity,%,0.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F,2013.0
Inhibition of MER (unknown origin) assessed as remaining activity at 10 uM relative to control,O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1,CHEMBL2346597,=,=,Activity,%,95.0,Activity,%,95.0,O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1,2013.0
Inhibition of MER (unknown origin) at 200 nM relative to control,CC(C)[S+]([O-])c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl,CHEMBL2346606,>,>,Inhibition,%,90.0,INH,%,90.0,CC(C)[S+]([O-])c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl,2013.0
Inhibition of MER (588 to 855) (unknown origin) by fluorescence assay,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL2346606,=,=,IC50,nM,11300.0,IC50,uM,11.3,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2013.0
Inhibition of MER (unknown origin),CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL2346606,=,=,IC50,nM,2.9,IC50,nM,2.9,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2013.0
Binding affinity to MER (unknown origin),COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,CHEMBL2346606,=,=,Kd,nM,1400.0,Kd,nM,1400.0,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1,2013.0
Inhibition of MER (unknown origin) assessed as remaining activity at 1 uM relative to control,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,CHEMBL2346597,=,=,Activity,%,104.0,Activity,%,104.0,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,2013.0
Inhibition of MER (unknown origin) assessed as remaining activity at 10 uM relative to control,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,CHEMBL2346597,=,=,Activity,%,102.0,Activity,%,102.0,CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1,2013.0
Inhibition of c-MER (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,CHEMBL2346629,=,=,Activity,%,86.0,Activity,%,86.0,CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1,2013.0
Inhibition of MERTK (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs,Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1,CHEMBL2390926,,,Inhibition,%,,INH,,,Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1,2013.0
Inhibition of MERTK (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs,Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl,CHEMBL2390926,,,Inhibition,%,,INH,,,Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl,2013.0
Inhibition of MERTK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,CHEMBL2390926,,,Inhibition,%,,INH,,,Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1,2013.0
Inhibition of MERTK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1,CHEMBL2390926,,,Inhibition,%,,INH,,,Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1,2013.0
Inhibition of MERTK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs,COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1,CHEMBL2390926,,,Inhibition,%,,INH,,,COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1,2013.0
Inhibition of MERTK (unknown origin) at 10 uM relative to control,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,CHEMBL2401733,=,=,Inhibition,%,9.0,INH,%,9.0,CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1,2013.0
Competitive binding affinity to MERTK (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1,CHEMBL2424622,<,<,Inhibition,%,50.0,INH,%,50.0,O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1,2013.0
Competitive binding affinity to MERTK (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1,CHEMBL2424622,=,=,Inhibition,%,100.0,INH,%,100.0,O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1,2013.0
Competitive binding affinity to MERTK (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1,CHEMBL2424622,=,=,Inhibition,%,92.0,INH,%,92.0,O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1,2013.0
Competitive binding affinity to MERTK (unknown origin) at 10 uM in presence of ATP relative to control,O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,CHEMBL2424622,<,<,Inhibition,%,50.0,INH,%,50.0,O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,CHEMBL3091325,=,=,Inhibition,%,100.0,INH,%,100.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,CHEMBL3091325,=,=,Inhibition,%,82.0,INH,%,82.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,CHEMBL3091325,=,=,Inhibition,%,73.0,INH,%,73.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,CHEMBL3091325,,,Inhibition,%,,INH,,,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,CHEMBL3091325,=,=,Inhibition,%,95.0,INH,%,95.0,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,CHEMBL3091325,=,=,Inhibition,%,94.0,INH,%,94.0,Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,=,=,Inhibition,%,49.0,INH,%,49.0,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,=,=,Inhibition,%,93.0,INH,%,93.0,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,=,=,Inhibition,%,90.0,INH,%,90.0,O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,83.0,INH,%,83.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,93.0,INH,%,93.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,89.0,INH,%,89.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,CHEMBL3091325,=,=,Inhibition,%,99.0,INH,%,99.0,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,CHEMBL3091325,=,=,Inhibition,%,65.0,INH,%,65.0,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,CHEMBL3091325,=,=,Inhibition,%,53.0,INH,%,53.0,Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,87.0,INH,%,87.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,71.0,INH,%,71.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,CHEMBL3091325,=,=,Inhibition,%,50.0,INH,%,50.0,Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,,,Inhibition,%,,INH,,,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,=,=,Inhibition,%,93.0,INH,%,93.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL3091325,=,=,Inhibition,%,77.0,INH,%,77.0,O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2013.0
Inhibition of Mer (unknown origin) at 75 uM relative to control,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL3091325,=,=,Inhibition,%,95.0,INH,%,95.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2013.0
Inhibition of Mer (unknown origin) at 1 uM relative to control,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL3091325,=,=,Inhibition,%,98.0,INH,%,98.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2013.0
Inhibition of Mer (unknown origin) at 0.5 uM relative to control,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL3091325,=,=,Inhibition,%,98.0,INH,%,98.0,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2013.0
Inhibition of Mer kinase phosphorylation in human 697 B-ALL cells after 1 hr by Western blot analysis,CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,22.0,IC50,nM,22.0,CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(N2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,>,>,IC50,nM,30000.0,IC50,uM,30.0,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(N2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CN(C)c1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,>,>,IC50,nM,30000.0,IC50,uM,30.0,CN(C)c1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCc2ccc(F)cc2)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,120.0,IC50,uM,0.12,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCc2ccc(F)cc2)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,180.0,IC50,uM,0.18,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCCCC2)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,47.0,IC50,uM,0.047,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCCCC2)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CC(C)Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,24.0,IC50,uM,0.024,CC(C)Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCO)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,59.0,IC50,uM,0.059,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCO)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCC(F)(F)F)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,86.0,IC50,uM,0.086,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCC(F)(F)F)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCC2CC2)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,7.3,IC50,uM,0.0073,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCC2CC2)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,27.0,IC50,uM,0.027,CCCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,11.0,IC50,uM,0.011,CCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,37.0,IC50,uM,0.037,CCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,150.0,IC50,uM,0.15,CNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,2400.0,IC50,uM,2.4,Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N2CCOCC2)n1,CHEMBL3091375,=,=,IC50,nM,9900.0,IC50,uM,9.9,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N2CCOCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCOCC2)n1,CHEMBL3091375,=,=,IC50,nM,170.0,IC50,uM,0.17,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCOCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCc2ccncc2)n1,CHEMBL3091375,=,=,IC50,nM,620.0,IC50,uM,0.62,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCc2ccncc2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CCNC2)n1,CHEMBL3091375,=,=,IC50,nM,110.0,IC50,uM,0.11,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CCNC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@@H]2CCNC2)n1,CHEMBL3091375,=,=,IC50,nM,1000.0,IC50,uM,1.0,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@@H]2CCNC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCNCC2)n1,CHEMBL3091375,=,=,IC50,nM,62.0,IC50,uM,0.062,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCNCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC[C@@H]2CCCNC2)n1,CHEMBL3091375,=,=,IC50,nM,140.0,IC50,uM,0.14,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC[C@@H]2CCCNC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCC2CCNCC2)n1,CHEMBL3091375,=,=,IC50,nM,37.0,IC50,uM,0.037,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCC2CCNCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCCCC2)n1,CHEMBL3091375,=,=,IC50,nM,590.0,IC50,uM,0.59,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCCCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](N)CC2)n1,CHEMBL3091375,=,=,IC50,nM,2.1,IC50,uM,0.0021,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](N)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,4.3,IC50,uM,0.0043,CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,5.2,IC50,uM,0.0052,CCCCNc1ncc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NCc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,14.0,IC50,uM,0.014,CCCCNc1ncc(C(=O)NCc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,6.3,IC50,uM,0.0063,CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(CN3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,6.7,IC50,uM,0.0067,CCCCNc1ncc(C(=O)Nc2ccc(CN3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,14.0,IC50,uM,0.014,CCCCNc1ncc(C(=O)Nc2ccc(N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccccc2OC)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,39.0,IC50,uM,0.039,CCCCNc1ncc(C(=O)Nc2ccccc2OC)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2cccc(OC)c2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,29.0,IC50,uM,0.029,CCCCNc1ncc(C(=O)Nc2cccc(OC)c2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(OC)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,15.0,IC50,uM,0.015,CCCCNc1ncc(C(=O)Nc2ccc(OC)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(C(F)(F)F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,230.0,IC50,uM,0.23,CCCCNc1ncc(C(=O)Nc2ccc(C(F)(F)F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NC2CCCCC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,8.0,IC50,uM,0.008,CCCCNc1ncc(C(=O)NC2CCCCC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NC2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,13.0,IC50,uM,0.013,CCCCNc1ncc(C(=O)NC2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NC2CCN(c3ncccn3)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,4.1,IC50,uM,0.0041,CCCCNc1ncc(C(=O)NC2CCN(c3ncccn3)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NC2CCN(C(C)C)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,8.4,IC50,uM,0.0084,CCCCNc1ncc(C(=O)NC2CCN(C(C)C)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)N2CCC(N)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,2500.0,IC50,uM,2.5,CCCCNc1ncc(C(=O)N2CCC(N)CC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)NC2CCNCC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,9.0,IC50,uM,0.009,CCCCNc1ncc(C(=O)NC2CCNCC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)N(C)CCCC)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,5900.0,IC50,uM,5.9,CCCCNc1ncc(C(=O)N(C)CCCC)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNC(=O)c1cnc(NCCCC)nc1N[C@H]1CC[C@H](O)CC1,CHEMBL3091375,=,=,IC50,nM,67.0,IC50,uM,0.067,CCCCNC(=O)c1cnc(NCCCC)nc1N[C@H]1CC[C@H](O)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,>,>,IC50,nM,30000.0,IC50,uM,30.0,CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091375,=,=,IC50,nM,23.0,IC50,uM,0.023,CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1,CHEMBL3091375,=,=,IC50,nM,12600.0,IC50,uM,12.6,CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1,CHEMBL3091375,=,=,IC50,nM,40.0,IC50,uM,0.04,CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NC[C@H]2CC[C@H](N)CC2)n1,CHEMBL3091310,=,=,IC50,nM,18.0,IC50,nM,18.0,CCCCNc1ncc(-c2ccccn2)c(NC[C@H]2CC[C@H](N)CC2)n1,2013.0
Inhibition of Mer kinase phosphorylation in human Colo699 cells after 72 hrs by Western blot analysis,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,,,Inhibition,%,,INH,,,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase phosphorylation in human 697 B-ALL cells after 1 hr by Western blot analysis,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,9.8,IC50,nM,9.8,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,OCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,44.0,IC50,nM,44.0,OCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,OCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,220.0,IC50,nM,220.0,OCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,OCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,320.0,IC50,nM,320.0,OCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O[C@H]1CC[C@H](Nc2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1,CHEMBL3091310,=,=,IC50,nM,14.0,IC50,nM,14.0,O[C@H]1CC[C@H](Nc2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O[C@H]1CC[C@H](Nc2nc(NCc3ccccc3)ncc2-c2ccccn2)CC1,CHEMBL3091310,=,=,IC50,nM,110.0,IC50,nM,110.0,O[C@H]1CC[C@H](Nc2nc(NCc3ccccc3)ncc2-c2ccccn2)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O[C@H]1CC[C@H](Nc2nc(NC3CCCCC3)ncc2-c2ccccn2)CC1,CHEMBL3091310,=,=,IC50,nM,83.0,IC50,nM,83.0,O[C@H]1CC[C@H](Nc2nc(NC3CCCCC3)ncc2-c2ccccn2)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,O[C@H]1CC[C@H](Nc2nc(N3CCCCC3)ncc2-c2ccccn2)CC1,CHEMBL3091310,=,=,IC50,nM,16500.0,IC50,nM,16500.0,O[C@H]1CC[C@H](Nc2nc(N3CCCCC3)ncc2-c2ccccn2)CC1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCN(C)c1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,380.0,IC50,nM,380.0,CCCCN(C)c1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCC(C)Nc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,44.0,IC50,nM,44.0,CCCC(C)Nc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,19.0,IC50,nM,19.0,CCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,50.0,IC50,nM,50.0,CCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,170.0,IC50,nM,170.0,CCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,540.0,IC50,nM,540.0,CNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CSc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,2700.0,IC50,nM,2700.0,CSc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N2CCNCC2)n1,CHEMBL3091310,>,>,IC50,nM,30000.0,IC50,nM,30000.0,CCCCNc1ncc(-c2ccccn2)c(N2CCNCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NCCCCO)n1,CHEMBL3091310,=,=,IC50,nM,600.0,IC50,nM,600.0,CCCCNc1ncc(-c2ccccn2)c(NCCCCO)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NCCCO)n1,CHEMBL3091310,=,=,IC50,nM,1130.0,IC50,nM,1130.0,CCCCNc1ncc(-c2ccccn2)c(NCCCO)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2C[C@H](O)C2)n1,CHEMBL3091310,=,=,IC50,nM,200.0,IC50,nM,200.0,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2C[C@H](O)C2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N[C@@H]2CC[C@@H](O)C2)n1,CHEMBL3091310,=,=,IC50,nM,160.0,IC50,nM,160.0,CCCCNc1ncc(-c2ccccn2)c(N[C@@H]2CC[C@@H](O)C2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NCC2CCNCC2)n1,CHEMBL3091310,=,=,IC50,nM,72.0,IC50,nM,72.0,CCCCNc1ncc(-c2ccccn2)c(NCC2CCNCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NC2CCNCC2)n1,CHEMBL3091310,=,=,IC50,nM,34.0,IC50,nM,34.0,CCCCNc1ncc(-c2ccccn2)c(NC2CCNCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(Nc2ccc(N)cc2)n1,CHEMBL3091310,=,=,IC50,nM,18.0,IC50,nM,18.0,CCCCNc1ncc(-c2ccccn2)c(Nc2ccc(N)cc2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](CN)CC2)n1,CHEMBL3091310,=,=,IC50,nM,4.5,IC50,nM,4.5,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](CN)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](N)CC2)n1,CHEMBL3091310,=,=,IC50,nM,1.8,IC50,nM,1.8,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](N)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(NC2CCCCC2)n1,CHEMBL3091310,=,=,IC50,nM,1250.0,IC50,nM,1250.0,CCCCNc1ncc(-c2ccccn2)c(NC2CCCCC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CNCCO)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,0.81,IC50,nM,0.81,CCCCNc1ncc(-c2ccc(CNCCO)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CNC3CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,1.3,IC50,nM,1.3,CCCCNc1ncc(-c2ccc(CNC3CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CNC3CCCCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,0.69,IC50,nM,0.69,CCCCNc1ncc(-c2ccc(CNC3CCCCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(NC(=O)C3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,3.4,IC50,nM,3.4,CCCCNc1ncc(-c2ccc(NC(=O)C3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(C(=O)NC3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,0.69,IC50,nM,0.69,CCCCNc1ncc(-c2ccc(C(=O)NC3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(S(=O)(=O)N3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,0.7,IC50,nM,0.7,CCCCNc1ncc(-c2ccc(S(=O)(=O)N3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CN(C)C)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,1.7,IC50,nM,1.7,CCCCNc1ncc(-c2ccc(CN(C)C)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CN3CCC(F)(F)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,1.1,IC50,nM,1.1,CCCCNc1ncc(-c2ccc(CN3CCC(F)(F)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2cccc(CN3CCOCC3)n2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,18.0,IC50,nM,18.0,CCCCNc1ncc(-c2cccc(CN3CCOCC3)n2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2cc(CN3CCOCC3)ccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,12.0,IC50,nM,12.0,CCCCNc1ncc(-c2cc(CN3CCOCC3)ccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ncccc2CN2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,>,>,IC50,nM,30000.0,IC50,nM,30000.0,CCCCNc1ncc(-c2ncccc2CN2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,1.7,IC50,nM,1.7,CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(CN3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,3.9,IC50,nM,3.9,CCCCNc1ncc(-c2ccc(CN3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(N3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,2.8,IC50,nM,2.8,CCCCNc1ncc(-c2ccc(N3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(F)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,6.3,IC50,nM,6.3,CCCCNc1ncc(-c2ccc(F)cn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1nccc(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,15200.0,IC50,nM,15200.0,CCCCNc1nccc(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,950.0,IC50,nM,950.0,CCCCNc1ncc(-c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,17.0,IC50,nM,17.0,CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,CCCCNc1ncc(-c2cccnc2)c(N[C@H]2CC[C@H](O)CC2)n1,CHEMBL3091310,=,=,IC50,nM,570.0,IC50,nM,570.0,CCCCNc1ncc(-c2cccnc2)c(N[C@H]2CC[C@H](O)CC2)n1,2013.0
Inhibition of human Mer assessed as residual activity at 1 uM relative to control,O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O,CHEMBL3098105,=,=,Activity,%,95.0,Activity,%,95.0,O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O,2014.0
Inhibition of MER (unknown origin) at 10 uM after 30 mins relative to control,COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC,CHEMBL3112530,=,=,Inhibition,%,9.8,INH,%,9.8,COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC,2014.0
Inhibition of human Mer assessed as enzyme activity at 1 uM relative to control,CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N,CHEMBL3232845,=,=,Activity,%,89.5,Activity,%,89.5,CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N,2014.0
Inhibition of Mer (unknown origin) after 60 mins by ELISA,CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl,CHEMBL3351234,>,>,IC50,nM,1000.0,IC50,uM,1.0,CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl,2015.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)cc2)CC1,CHEMBL3351548,=,=,IC50,nM,1.3,IC50,nM,1.3,CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)cc2)CC1,2014.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,0.74,IC50,nM,0.74,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CN1CCN(S(=O)(=O)c2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)c(F)c2)CC1,CHEMBL3351548,=,=,IC50,nM,1.6,IC50,nM,1.6,CN1CCN(S(=O)(=O)c2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)c(F)c2)CC1,2014.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)c(F)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,0.57,IC50,nM,0.57,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)c(F)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,Ki,nM,0.33,Ki,nM,0.33,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer (unknown origin) by Off-chip Mobility Shift Assay,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,1.1,IC50,nM,1.1,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer phosphorylation in human 697 cells by ATP ActivX probe assay,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,,,Inhibition,%,,INH,,,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer phosphorylation in human 697 cells preincubated for 1 hr by densitometry,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,2.7,IC50,nM,2.7,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer-mediated colony formation in human A549 cells at 50 to 300 nM measured after 2 weeks by soft agar colony formation assay,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,,,Inhibition,%,,INH,,,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer-mediated colony formation in human A549 cells at 300 nM measured after 2 weeks by soft agar colony formation assay,CCCCN(C)c1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,,,Inhibition,%,,INH,,,CCCCN(C)c1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of EGFR extracellular/transmembrane domain-tagged Mer intracellular domain (unknown origin) expressed in 32D cells assessed as inhibition EGF-stimulated of phosphorylation pretreated for 1 hr prior to EGF stimulation by Western blot analysis,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,2.7,IC50,nM,2.7,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of Mer (unknown origin),CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL3351548,=,=,IC50,nM,1.1,IC50,nM,1.1,CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1,2014.0
Inhibition of MERTK (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay,COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O,CHEMBL3351621,=,=,Activity,%,44.0,Activity,%,44.0,COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O,2015.0
Competitive binding affinity to human MERTK,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,CHEMBL3414433,=,=,Kd,nM,150.0,Kd,nM,150.0,NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12,2015.0
"Inhibition of Mer (unknown origin) using polu (Glu,Tyr)4:1 substrate after 30 mins incubation by multi-well spectrophotometry",CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,CHEMBL3580555,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F,2015.0
Inhibition of Tel-fused MER (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3,OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1,CHEMBL3580662,=,=,IC50,nM,5100.0,IC50,uM,5.1,OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1,2015.0
Inhibition of Tel-fused MER (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3,O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1,CHEMBL3580662,=,=,IC50,nM,4700.0,IC50,uM,4.7,O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1,2015.0
Inhibition of Tel-fused MER (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3,N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1,CHEMBL3580662,=,=,IC50,nM,5400.0,IC50,uM,5.4,N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1,2015.0
Inhibition of c-MER (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1,CHEMBL3627608,=,=,Inhibition,%,98.16,INH,%,98.16,CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1,2015.0
Inhibition of c-MER (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1,CHEMBL3627608,=,=,Inhibition,%,77.94,INH,%,77.94,CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1,2015.0
Inhibition of c-MER (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC,CHEMBL3627608,=,=,Inhibition,%,30.83,INH,%,30.83,COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC,2015.0
Inhibition of Mer (unknown origin) at 1 uM,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,CHEMBL3745631,=,=,Inhibition,%,3.0,INH,%,3.0,Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1,2016.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,CHEMBL3745707,>,>,IC50,nM,10000.0,IC50,uM,10.0,Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21,2016.0
Inhibition of MER (unknown origin) at 100 nM,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,CHEMBL3758169,=,=,Inhibition,%,6.3,INH,%,6.3,CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21,2016.0
"Inhibition of recombinant human Mer using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA",Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1,CHEMBL3758137,>,>,IC50,nM,1000.0,IC50,nM,1000.0,Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1,2016.0
"Inhibition of recombinant human Mer using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA",C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,CHEMBL3758137,>,>,IC50,nM,100.0,IC50,nM,100.0,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2016.0
Inhibition of N-terminal His6-tagged recombinant human MER expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,CHEMBL3774357,=,=,Activity,%,-4.0,Activity,%,-4.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1,2016.0
Inhibition of N-terminal His6-tagged recombinant human MER expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,CHEMBL3774357,=,=,Activity,%,5.0,Activity,%,5.0,Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1,2016.0
Inhibition of N-terminal His6-tagged recombinant human MER expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,CHEMBL3774357,=,=,Activity,%,-1.0,Activity,%,-1.0,CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1,2016.0
Inhibition of human MER at 1 uM after 30 mins by fluorescence assay in presence of ATP,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C,CHEMBL3784918,=,=,Inhibition,%,100.0,INH,%,100.0,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C,2016.0
"Inhibition of recombinant c-Mer (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 60 mins by ELISA",Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,CHEMBL3797175,>,>,IC50,nM,1000.0,IC50,uM,1.0,Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,2016.0
"Inhibition of recombinant c-Mer (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control",Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,CHEMBL3797175,=,=,Inhibition,%,13.5,INH,%,13.5,Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1,2016.0
Inhibition of GST-tagged human recombinant cMER expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,CHEMBL3808348,<,<,Inhibition,%,40.0,INH,%,40.0,COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1,2016.0
Inhibition of human recombinant MER by fluorescence polarization assay,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,CHEMBL3808287,>,>,IC50,nM,700.0,IC50,nM,700.0,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(N(C)c2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,1140.0,IC50,uM,1.14,COc1ccc(N(C)c2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(N(C)c2nc(NCCCO)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,2010.0,IC50,uM,2.01,COc1ccc(N(C)c2nc(NCCCO)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CCCNc1nc(N(C)c2ccc(OC)cc2)nc2ccccc12,CHEMBL3808351,=,=,IC50,nM,1840.0,IC50,uM,1.84,CCCNc1nc(N(C)c2ccc(OC)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CNc1nc(N(C)c2ccc(OC)cc2)nc2ccccc12,CHEMBL3808351,=,=,IC50,nM,10200.0,IC50,uM,10.2,CNc1nc(N(C)c2ccc(OC)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(N(C)c2nc(N3CCOCC3)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,COc1ccc(N(C)c2nc(N3CCOCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(N(C)c2nc(NCC3CCOCC3)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,COc1ccc(N(C)c2nc(NCC3CCOCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,N#Cc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,N#Cc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Nc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,7270.0,IC50,uM,7.27,Nc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,CHEMBL3808351,=,=,IC50,nM,4900.0,IC50,uM,4.9,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL3808351,=,=,IC50,nM,83.0,IC50,uM,0.083,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Fc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,4170.0,IC50,uM,4.17,Fc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Oc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,1240.0,IC50,uM,1.24,Oc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,O=C(O)c1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,2900.0,IC50,uM,2.9,O=C(O)c1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,N#Cc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,1720.0,IC50,uM,1.72,N#Cc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Nc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,Nc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,OCCCNc1nc(Nc2ccc(F)cc2)nc2ccccc12,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,OCCCNc1nc(Nc2ccc(F)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CCCNc1nc(Nc2ccc(F)cc2)nc2ccccc12,CHEMBL3808351,=,=,IC50,nM,7840.0,IC50,uM,7.84,CCCNc1nc(Nc2ccc(F)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Fc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,Fc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,Nc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,CHEMBL3808351,>,>,IC50,nM,30000.0,IC50,uM,30.0,Nc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(Nc2nc(NC3CC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,3560.0,IC50,uM,3.56,COc1ccc(Nc2nc(NC3CC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,2060.0,IC50,uM,2.06,COc1ccc(Nc2nc(N3CCOCC3)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CNc1nc(Nc2ccc(OC)cc2)nc2ccccc12,CHEMBL3808351,=,=,IC50,nM,2250.0,IC50,uM,2.25,CNc1nc(Nc2ccc(OC)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,CCCNc1nc(Nc2ccc(OC)cc2)nc2ccccc12,CHEMBL3808351,=,=,IC50,nM,3430.0,IC50,uM,3.43,CCCNc1nc(Nc2ccc(OC)cc2)nc2ccccc12,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,680.0,IC50,uM,0.68,COc1ccc(Nc2nc(NCCCO)c3ccccc3n2)cc1,2016.0
Inhibition of MERTK (unknown origin) using EFPIYDFLPAKKK-CONH2 as substrate and ATP after 180 mins by microfluidic capillary electrophoresis method,COc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,CHEMBL3808351,=,=,IC50,nM,1080.0,IC50,uM,1.08,COc1ccc(Nc2nc(NC3CCCC3)c3ccccc3n2)cc1,2016.0
Inhibition of N-terminal His-tagged Mer kinase (588 to 855 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells measured every min by ADP Quest Assay,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,CHEMBL3808351,=,=,IC50,nM,11300.0,IC50,uM,11.3,CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21,2016.0
Inhibition of human c-MER at 1 uM using poly[Glu:Tyr] (4:1) as substrate,CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1,CHEMBL3813650,=,=,Inhibition,%,-5.0,INH,%,-5.0,CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1,2016.0
Inhibition of recombinant human GST-tagged cytoplasmic MER (578 to 872 residues) expressed in baculovirus expression system at 1 uM relative to control,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,CHEMBL3813614,<,<,Inhibition,%,50.0,INH,%,50.0,CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12,2016.0
Inhibition of recombinant human GST-tagged Mer expressed in Baculovirus at 1 uM relative to control,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,CHEMBL3817726,>,>,Inhibition,%,75.0,INH,%,75.0,Cc1nc(Nc2n[nH]c3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(C4CCOCC4)cn(c3n2)CCCC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,OC1CCCCCCCNc2ncc3c(C4CCOCC4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccncc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,EC50,nM,260.0,EC50,nM,260.0,OC1CCCCCCCNc2ncc3c(-c4ccncc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4cccnc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,EC50,nM,380.0,EC50,nM,380.0,OC1CCCCCCCNc2ncc3c(-c4cccnc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccccn4)cn(c3n2)CCCC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,OC1CCCCCCCNc2ncc3c(-c4ccccn4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccc(N5CCOCC5)cc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,EC50,nM,690.0,EC50,nM,690.0,OC1CCCCCCCNc2ncc3c(-c4ccc(N5CCOCC5)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,O=C(Nc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,EC50,nM,490.0,EC50,nM,490.0,O=C(Nc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,O=S(=O)(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,EC50,nM,220.0,EC50,nM,220.0,O=S(=O)(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,O=C(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,EC50,nM,210.0,EC50,nM,210.0,O=C(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccc(CN5CCOCC5)cc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,EC50,nM,160.0,EC50,nM,160.0,OC1CCCCCCCNc2ncc3c(-c4ccc(CN5CCOCC5)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,COc1ccccc1-c1cn2c3nc(ncc13)NCCCCCCCC(O)CCCC2,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,COc1ccccc1-c1cn2c3nc(ncc13)NCCCCCCCC(O)CCCC2,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,COc1cccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)c1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,COc1cccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)c1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,COc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,COc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccc(F)cc4)cn(c3n2)CCCC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,OC1CCCCCCCNc2ncc3c(-c4ccc(F)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,OC1CCCCCCCNc2ncc3c(-c4ccccc4)cn(c3n2)CCCC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,OC1CCCCCCCNc2ncc3c(-c4ccccc4)cn(c3n2)CCCC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,400.0,EC50,nM,400.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,150.0,EC50,nM,150.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,120.0,EC50,nM,120.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,69.0,EC50,nM,69.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,72.0,EC50,nM,72.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,110.0,EC50,nM,110.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,150.0,EC50,nM,150.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,190.0,EC50,nM,190.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,43.0,EC50,nM,43.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,240.0,EC50,nM,240.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,39.0,EC50,nM,39.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,160.0,EC50,nM,160.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,=,=,EC50,nM,34.0,EC50,nM,34.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,>,>,EC50,nM,1000.0,EC50,nM,1000.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,65.0,IC50,nM,65.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(C4CCOCC4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,94.0,IC50,nM,94.0,OC1CCCCCCCNc2ncc3c(C4CCOCC4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccncc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,80.0,IC50,nM,80.0,OC1CCCCCCCNc2ncc3c(-c4ccncc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4cccnc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,13.0,IC50,nM,13.0,OC1CCCCCCCNc2ncc3c(-c4cccnc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccccn4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,54.0,IC50,nM,54.0,OC1CCCCCCCNc2ncc3c(-c4ccccn4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccc(N5CCOCC5)cc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,32.0,IC50,nM,32.0,OC1CCCCCCCNc2ncc3c(-c4ccc(N5CCOCC5)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,O=C(Nc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,IC50,nM,30.0,IC50,nM,30.0,O=C(Nc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,O=S(=O)(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,IC50,nM,11.0,IC50,nM,11.0,O=S(=O)(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,O=C(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,CHEMBL3864173,=,=,IC50,nM,8.1,IC50,nM,8.1,O=C(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccc(CN5CCOCC5)cc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,16.0,IC50,nM,16.0,OC1CCCCCCCNc2ncc3c(-c4ccc(CN5CCOCC5)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,COc1ccccc1-c1cn2c3nc(ncc13)NCCCCCCCC(O)CCCC2,CHEMBL3864173,=,=,IC50,nM,170.0,IC50,nM,170.0,COc1ccccc1-c1cn2c3nc(ncc13)NCCCCCCCC(O)CCCC2,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,COc1cccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)c1,CHEMBL3864173,=,=,IC50,nM,160.0,IC50,nM,160.0,COc1cccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)c1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,COc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1,CHEMBL3864173,=,=,IC50,nM,86.0,IC50,nM,86.0,COc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccc(F)cc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,150.0,IC50,nM,150.0,OC1CCCCCCCNc2ncc3c(-c4ccc(F)cc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,OC1CCCCCCCNc2ncc3c(-c4ccccc4)cn(c3n2)CCCC1,CHEMBL3864173,=,=,IC50,nM,140.0,IC50,nM,140.0,OC1CCCCCCCNc2ncc3c(-c4ccccc4)cn(c3n2)CCCC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,4.9,IC50,nM,4.9,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,3.1,IC50,nM,3.1,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,5.0,IC50,nM,5.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,4.1,IC50,nM,4.1,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,2.6,IC50,nM,2.6,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,3.0,IC50,nM,3.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,4.0,IC50,nM,4.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,8.0,IC50,nM,8.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,9.6,IC50,nM,9.6,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,1.8,IC50,nM,1.8,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,5.6,IC50,nM,5.6,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,4.1,IC50,nM,4.1,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,0.8,IC50,nM,0.8,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,2.2,IC50,nM,2.2,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,8.9,IC50,nM,8.9,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,30.0,IC50,nM,30.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,17.0,IC50,nM,17.0,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of MerTK (unknown origin) by microfluidic capillary electrophoresis assay,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,CHEMBL3864173,=,=,IC50,nM,3.9,IC50,nM,3.9,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1,2016.0
Inhibition of human MerTK kinase domain (1585 to 3000 residues) expressed in HEK293 cells co-expressing rat EGFR LBD assessed as inhibition of EGF-stimulated MerTK phosphorylation preincubated for 30 mins followed by EGF stimulation for 15 mins by ELISA,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCC4)cc2)CC1,CHEMBL3864173,,,EC50,,,EC50,,,CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCC4)cc2)CC1,2016.0
Inhibition of human recombinant GST-tagged MERTK cytoplasmic domain (578 to 872 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay,Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1,CHEMBL3868614,=,=,Inhibition,%,68.0,INH,%,68.0,Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1,2016.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1,CHEMBL3991601,=,=,Kd,nM,2810.0,Kd apparent,nM,2810.0,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL3991601,=,=,Kd,nM,41.0,Kd apparent,nM,41.0,COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=c1[nH]ccc2cc(OC3CCNCC3)ccc12,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1,CHEMBL3991601,=,=,Kd,nM,18.0,Kd apparent,nM,18.0,Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1,2017.0
"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,CHEMBL3991601,>,>,Kd,nM,30000.0,Kd apparent,nM,30000.0,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1,2017.0
Inhibition of recombinant human GST-tagged MER cytoplasmic domain expressed in baculovirus expression system,CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1,CHEMBL4007491,=,=,IC50,nM,6456.54,pIC50,,5.19,CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1,2017.0
Inhibition of recombinant human GST-tagged MER cytoplasmic domain expressed in baculovirus expression system,COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1,CHEMBL4007491,=,=,IC50,nM,7585.78,pIC50,,5.12,COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1,2017.0
Inhibition of MER (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control,COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O,CHEMBL4011589,=,=,Inhibition,%,0.2,INH,%,0.2,COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O,2017.0
"Inhibition of recombinant Mer (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12,CHEMBL4017490,=,=,IC50,nM,30.9,IC50,nM,30.9,Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12,2017.0
"Inhibition of recombinant Mer (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1,CHEMBL4017490,=,=,IC50,nM,4.4,IC50,nM,4.4,OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1,2017.0
"Inhibition of recombinant Mer (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12,CHEMBL4017490,=,=,IC50,nM,36.9,IC50,nM,36.9,Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12,2017.0
"Inhibition of recombinant Mer (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12,CHEMBL4017490,=,=,IC50,nM,7.1,IC50,nM,7.1,Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12,2017.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,CHEMBL4024706,=,=,Activity,%,100.0,Activity,%,100.0,C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1,2017.0
Inhibition of MER (unknown origin) labeling at activation loop (KIYSGDYYR) at 10 uM relative to control,c1cc(-c2c[nH]c3cnccc23)ccn1,CHEMBL4033637,=,=,Inhibition,%,1.2,INH,%,1.2,c1cc(-c2c[nH]c3cnccc23)ccn1,2017.0
Inhibition of MER activation loop (unknown origin) at 10 uM,c1cc(-c2c[nH]c3cnccc23)ccn1,CHEMBL4033637,=,=,Inhibition,%,-5.3,INH,%,-5.3,c1cc(-c2c[nH]c3cnccc23)ccn1,2017.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,CHEMBL4043093,=,=,Activity,%,85.0,Activity,%,85.0,COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl,2017.0
Inhibition of wild type human partial length MER (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity by Kinome scan assay relative to control,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,CHEMBL4043252,<,<,Activity,%,10.0,Activity,%,10.0,CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO,2017.0
Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,CHEMBL4052645,=,=,Activity,%,100.0,Activity,%,100.0,CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N,2017.0
Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,CHEMBL4052645,=,=,Activity,%,100.0,Activity,%,100.0,COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1,2017.0
Inhibition of Mer (unknown origin) at 0.45 uM relative to control,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,CHEMBL4052759,=,=,Inhibition,%,0.7,INH,%,0.7,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,2017.0
Inhibition of Mer (unknown origin) at 0.49 uM relative to control,Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1,CHEMBL4052759,=,=,Inhibition,%,11.3,INH,%,11.3,Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1,2017.0
Inhibition of recombinant GST-tagged human Mer cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control,CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@H]1[C@@H]2CN(C3COC3)C[C@@H]21,CHEMBL4118097,=,=,Inhibition,%,22.5,INH,%,22.5,CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@H]1[C@@H]2CN(C3COC3)C[C@@H]21,2017.0
Inhibition of recombinant GST-tagged human Mer cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control,Nc1ncc(-c2cc([C@H]3[C@@H]4CN(C5COC5)C[C@@H]43)n(CC3CC3)n2)cc1C(F)(F)F,CHEMBL4118097,=,=,Inhibition,%,37.0,INH,%,37.0,Nc1ncc(-c2cc([C@H]3[C@@H]4CN(C5COC5)C[C@@H]43)n(CC3CC3)n2)cc1C(F)(F)F,2017.0
Inhibition of Mer (unknown origin) at 0.45 uM relative to control,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,CHEMBL4118098,=,=,Inhibition,%,0.7,INH,%,0.7,Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1,2017.0
Inhibition of Mer (unknown origin) at 0.19 uM relative to control,Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1,CHEMBL4118098,=,=,Inhibition,%,-4.0,INH,%,-4.0,Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1,2017.0
Inhibition of Mer (unknown origin) at 0.164 uM relative to control,COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12,CHEMBL4118098,=,=,Inhibition,%,6.0,INH,%,6.0,COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12,2017.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,CHEMBL4152344,=,=,Activity,%,82.0,Activity,%,82.0,Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1,2018.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,CHEMBL4184148,=,=,Activity,%,80.0,Activity,%,80.0,C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,2017.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,CHEMBL4184148,=,=,Activity,%,100.0,Activity,%,100.0,CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1,2017.0
Inhibition of MER (unknown origin),CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,CHEMBL4184298,=,=,IC50,nM,2.9,IC50,nM,2.9,CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1,2018.0
Inhibition of MER (unknown origin),CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1,CHEMBL4184298,=,=,IC50,nM,18.0,IC50,nM,18.0,CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1,CHEMBL4184298,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1,CHEMBL4184298,=,=,IC50,nM,2500.0,IC50,uM,2.5,CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1,CHEMBL4184298,=,=,IC50,nM,480.0,IC50,uM,0.48,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1,CHEMBL4184298,=,=,IC50,nM,92.0,IC50,uM,0.092,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,CHEMBL4184298,=,=,IC50,nM,15.0,IC50,uM,0.015,Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,CHEMBL4184298,=,=,IC50,nM,5400.0,IC50,uM,5.4,CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1,CHEMBL4184298,>,>,IC50,nM,10000.0,IC50,uM,10.0,CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,CHEMBL4184298,=,=,IC50,nM,2000.0,IC50,uM,2.0,CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,CHEMBL4184298,>,>,IC50,nM,10000.0,IC50,uM,10.0,CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1,CHEMBL4184298,=,=,IC50,nM,8900.0,IC50,uM,8.9,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,CHEMBL4184298,=,=,IC50,nM,2300.0,IC50,uM,2.3,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1,CHEMBL4184298,=,=,IC50,nM,8700.0,IC50,uM,8.7,CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1,CHEMBL4184298,=,=,IC50,nM,6200.0,IC50,uM,6.2,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1,2018.0
"Inhibition of wild-type human partial length MER (R557 to L884 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1,CHEMBL4184298,=,=,IC50,nM,640.0,IC50,uM,0.64,CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1,2018.0
Inhibition of recombinant human MER (557 to 882 residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method,CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1,CHEMBL4190187,=,=,Inhibition,%,-3.0,INH,%,-3.0,CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1,2017.0
Inhibition of MER (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21,CHEMBL4229333,=,=,Inhibition,%,6.0,INH,%,6.0,CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21,2018.0
Inhibition of MER (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control,CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21,CHEMBL4229333,=,=,Inhibition,%,0.0,INH,%,0.0,CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21,2018.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,CHEMBL4229344,=,=,Activity,%,100.0,Activity,%,100.0,Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1,2018.0
Inhibition of MER (unknown origin),O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,CHEMBL4229420,>,>,IC50,nM,1000.0,IC50,nM,1000.0,O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1,2018.0
Inhibition of MER (unknown origin),CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1,CHEMBL4229506,>,>,Ki,nM,2000.0,Ki,nM,2000.0,CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1,2018.0
Inhibition of MER (unknown origin),O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1,CHEMBL4229506,>,>,Ki,nM,2000.0,Ki,nM,2000.0,O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1,2018.0
Inhibition of MER (unknown origin),CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1,CHEMBL4229506,,,Ki,,,Ki,,,CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1,2018.0
Inhibition of recombinant human GST-tagged MERTK (578 to 872 residues) expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,CHEMBL4251601,=,=,Inhibition,%,-1.0,INH,%,-1.0,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,2018.0
Inhibition of recombinant human GST-tagged MERTK (578 to 872 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,CHEMBL4251601,=,=,Inhibition,%,13.0,INH,%,13.0,CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2,2018.0
Inhibition of recombinant human Mer H628Q/R794A double mutant (557 to 882 residues) using GGMEDIYFEFMGG as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis,CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21,CHEMBL4257593,=,=,IC50,nM,29.0,IC50,nM,29.0,CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21,2018.0
Inhibition of MER (unknown origin) at 1 uM relative to control,NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1,CHEMBL4261595,=,=,Inhibition,%,8.0,INH,%,8.0,NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1,2018.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,CHEMBL4261600,=,=,Activity,%,94.0,Activity,%,94.0,COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,IC50,nM,9.0,IC50,nM,9.0,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,IC50,nM,90.0,IC50,nM,90.0,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,CHEMBL4261615,=,=,IC50,nM,40.0,IC50,nM,40.0,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,CHEMBL4261615,>,>,IC50,nM,100000.0,IC50,uM,100.0,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,O=C(Nc1ccc(Oc2c(-c3ccccc3)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,,,Inhibition,%,,INH,,,O=C(Nc1ccc(Oc2c(-c3ccccc3)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,,,Inhibition,%,,INH,,,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,,,Inhibition,%,,INH,,,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,CHEMBL4261615,,,Inhibition,%,,INH,,,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1,2018.0
Inhibition of recombinant GST-tagged human Mer (578 to 872 residues) cytoplasmic domain expressed in Baculovirus system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1,CHEMBL4261615,,,Inhibition,%,,INH,,,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,4.0,Activity,%,4.0,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,87.0,Activity,%,87.0,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,CHEMBL4261615,=,=,Activity,%,92.3,Activity,%,92.3,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,CHEMBL4261615,=,=,Activity,%,17.0,Activity,%,17.0,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,60.0,Activity,%,60.0,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,99.3,Activity,%,99.3,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,CHEMBL4261615,=,=,Activity,%,99.6,Activity,%,99.6,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,CHEMBL4261615,=,=,Activity,%,78.0,Activity,%,78.0,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,98.2,Activity,%,98.2,O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,CHEMBL4261615,=,=,Activity,%,99.6,Activity,%,99.6,O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,CHEMBL4261615,=,=,Activity,%,99.1,Activity,%,99.1,CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1,2018.0
Binding affinity to wild-type partial length human MER (R557 to L884 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,CHEMBL4261615,=,=,Activity,%,99.1,Activity,%,99.1,Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F,2018.0
Inhibition of MERTK in human 697 cells assessed as reduction in phosphorylated MERTK level preincubated for 1 hr followed by pervanadate phopshatase inhibitor addition and measured after 3 mins by immunoblot analysis,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,13.8,IC50,nM,13.8,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CC[C@H](N(C)C)C4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,4.1,IC50,nM,4.1,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CC[C@H](N(C)C)C4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4C5CCC4CC5)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,2.0,IC50,nM,2.0,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4C5CCC4CC5)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3F)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.5,IC50,nM,3.5,CCC[C@H](C)Nc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3F)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,4.9,IC50,nM,4.9,CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCCCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,72.0,IC50,nM,72.0,CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCCCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of N-terminal GST-tagged human MERTK cytoplasmic domain (528 to 999 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,0.6,IC50,nM,0.6,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,Ki,nM,0.43,Ki,nM,0.43,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,2.4,IC50,nM,2.4,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.2,IC50,nM,3.2,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCC[C@H](CO)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,24.0,IC50,nM,24.0,CCCC[C@H](CO)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.6,IC50,nM,3.6,CCCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,2.6,IC50,nM,2.6,CCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F,CHEMBL4270664,=,=,IC50,nM,1068.0,IC50,nM,1068.0,CCC[C@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F,CHEMBL4270664,=,=,IC50,nM,20.0,IC50,nM,20.0,CCC[C@@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,22.0,IC50,nM,22.0,CCC[C@@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,4.3,IC50,nM,4.3,CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCCNc1ncc2c(-c3ccc(Oc4ccccc4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,78.0,IC50,nM,78.0,CCCCNc1ncc2c(-c3ccc(Oc4ccccc4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCCNc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,5.2,IC50,nM,5.2,CCCCNc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCCNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.5,IC50,nM,3.5,CCCCNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCCNc1ncc2c(-c3ccc(C4(N5CCN(C)CC5)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,1.3,IC50,nM,1.3,CCCCNc1ncc2c(-c3ccc(C4(N5CCN(C)CC5)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NC5CCCCC5)ncc34)cc2)CC1,CHEMBL4270664,=,=,IC50,nM,13.0,IC50,nM,13.0,CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NC5CCCCC5)ncc34)cc2)CC1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC(CC)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,19.0,IC50,nM,19.0,CCC(CC)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC(C)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,5.2,IC50,nM,5.2,CCC(C)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCCC(C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.5,IC50,nM,3.5,CCCC(C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,N[C@H]1CCCCNc2nc(ncc2C(=O)NCc2ccc(F)cc2)NCCCCCCNC1=O,CHEMBL4270664,=,=,IC50,nM,4.4,IC50,nM,4.4,N[C@H]1CCCCNc2nc(ncc2C(=O)NCc2ccc(F)cc2)NCCCCCCNC1=O,2018.0
Ratio of IC50 for MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay to IC50 for N-terminal GST-tagged human MERTK cytoplasmic domain (528 to 999 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,Ratio IC50,,16.0,Ratio IC50,,16.0,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of N-terminal GST-tagged human MERTK cytoplasmic domain (528 to 999 end residues) expressed in baculovirus expression system at 100 nM using fluorecence-labeled substrate by MCE assay relative to control,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,Inhibition,%,100.0,INH,%,100.0,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of N-terminal GST-tagged human MERTK cytoplasmic domain (528 to 999 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,0.46,IC50,nM,0.46,CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(C4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,61.0,IC50,nM,61.0,CCC[C@H](C)Nc1ncc2c(-c3ccc(C4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc(CNCCN(CC)CC)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,2.5,IC50,nM,2.5,CCC[C@H](C)Nc1ncc2c(-c3ccc(CNCCN(CC)CC)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3cccc(CN4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,4.9,IC50,nM,4.9,CCC[C@H](C)Nc1ncc2c(-c3cccc(CN4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3cccc(N4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,3.1,IC50,nM,3.1,CCC[C@H](C)Nc1ncc2c(-c3cccc(N4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccnc(N4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,1.2,IC50,nM,1.2,CCC[C@H](C)Nc1ncc2c(-c3ccnc(N4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccnc(C(=O)OC)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,4.9,IC50,nM,4.9,CCC[C@H](C)Nc1ncc2c(-c3ccnc(C(=O)OC)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3cnc(C4CC4)nc3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,13.0,IC50,nM,13.0,CCC[C@H](C)Nc1ncc2c(-c3cnc(C4CC4)nc3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3cnn(C4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,2.2,IC50,nM,2.2,CCC[C@H](C)Nc1ncc2c(-c3cnn(C4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Inhibition of MERTK (unknown origin) using 5'-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by MCE assay,CCC[C@H](C)Nc1ncc2c(-c3ccc4nc(C)oc4c3)cn([C@H]3CC[C@H](O)CC3)c2n1,CHEMBL4270664,=,=,IC50,nM,22.0,IC50,nM,22.0,CCC[C@H](C)Nc1ncc2c(-c3ccc4nc(C)oc4c3)cn([C@H]3CC[C@H](O)CC3)c2n1,2018.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,CHEMBL4304811,=,=,Activity,%,71.0,Activity,%,71.0,CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl,2019.0
Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MERTK (unknown origin) (528 to 999 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4321812,=,=,Kd,nM,107.0,Kd,nM,107.0,CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged MERTK (unknown origin) (528 to 999 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4321812,=,=,Kd,nM,108.0,Kd,nM,108.0,CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Inhibition of human recombinant GST-tagged cytoplasmic MER (578 to 872 residues) expressed in baculovirus expression system,CC(C)(C)NS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)ncc1Cl,CHEMBL4325842,=,=,Kd,nM,3500.0,Kd,uM,3.5,CC(C)(C)NS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)ncc1Cl,2018.0
Inhibition MER (unknown origin),COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,CHEMBL4325842,=,=,Kd,nM,19.0,Kd,uM,0.019,COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,2018.0
Inhibition of human MER at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1,CHEMBL4325842,=,=,Inhibition,%,90.6,INH,%,90.6,CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1,2018.0
Inhibition of human MER using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1,CHEMBL4325842,=,=,IC50,nM,25.0,IC50,uM,0.025,CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1,2018.0
Inhibition of human c-MER assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],CHEMBL4325871,=,=,Activity,%,101.09,Activity,%,101.09,ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],2019.0
Inhibition of human c-MER assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],CHEMBL4325871,=,=,Activity,%,97.38,Activity,%,97.38,C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-],2019.0
Inhibition of human c-MER assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4325871,<,<,Activity,%,65.0,Activity,%,65.0,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4325871,=,=,IC50,nM,11.6,IC50,10'-8M,1.16,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2019.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,CHEMBL4330132,=,=,Activity,%,100.0,Activity,%,100.0,CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N,2019.0
Inhibition of human c-MER at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP,CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1,CHEMBL4350963,,,Inhibition,%,,INH,,,CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1,2019.0
ATP competitive inhibition of human Mer,CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1,CHEMBL4350970,=,=,Ki,nM,30.0,Ki,nM,30.0,CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1,2019.0
"Inhibition of human C-MER using poly (Glu,Tyr)4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control",CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1,CHEMBL4350983,=,=,Inhibition,%,88.82,INH,%,88.82,CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1,2019.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,CHEMBL4354843,=,=,Activity,%,95.0,Activity,%,95.0,C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl,2020.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,CHEMBL4364269,=,=,Activity,%,65.0,Activity,%,65.0,O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1,2019.0
Inhibition of human c-MER at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,CHEMBL4364276,=,=,Inhibition,%,5.47,INH,%,5.47,COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1,2019.0
Inhibition of MER (unknown origin) at 1 uM relative to control,Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl,CHEMBL4364278,=,=,Inhibition,%,100.0,INH,%,100.0,Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl,2019.0
Inhibition of recombinant human GST-tagged cMER (578 to 872 residues) expressed in baculovirus infected Sf21 insect cells using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay,Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21,CHEMBL4373740,=,=,IC50,nM,4.2,IC50,nM,4.2,Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21,2020.0
Inhibition of recombinant human GST-tagged cMER (578 to 872 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control,Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21,CHEMBL4373740,>,>,Inhibition,%,80.0,INH,%,80.0,Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21,2020.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,CHEMBL4382192,=,=,Activity,%,2.7,Activity,%,2.7,C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C,2017.0
Inhibition of recombinant human GST-tagged MER (578 to 872 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,CHEMBL4385643,=,=,Inhibition,%,20.5,INH,%,20.5,CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1,2019.0
Inhibition of recombinant human GST-tagged MER (578 to 872 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,CHEMBL4385643,=,=,Inhibition,%,4.0,INH,%,4.0,CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2,2019.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,CHEMBL4387741,=,=,Inhibition,%,31.0,INH,%,31.0,O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1,2019.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,CHEMBL4387741,=,=,Inhibition,%,31.0,INH,%,31.0,O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1,2019.0
Binding affinity to wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,CHEMBL4390652,=,=,Activity,%,12.0,Activity,%,12.0,O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O,2019.0
Inhibition of wild-type human partial length MERTK (R557 to L884 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control,CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1,CHEMBL4402587,<,<,Inhibition,%,50.0,INH,%,50.0,CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1,2020.0
Binding affinity to human MER,CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C,CHEMBL4425136,=,=,Kd,nM,1.4,Kd,nM,1.4,CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C,2016.0
"Inhibition of recombinant MER (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl,CHEMBL4431350,=,=,Inhibition,%,113.9,INH,%,113.9,Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl,2016.0
"Inhibition of recombinant MER (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,CHEMBL4431350,=,=,Inhibition,%,112.6,INH,%,112.6,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,2016.0
Inhibition of human MER incubated for 90 mins by ELISA method,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,CHEMBL4433204,=,=,IC50,nM,1370.0,IC50,uM,1.37,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,2019.0
Inhibition of human MER incubated for 90 mins by ELISA method,O=C(Nc1cccc(NC(=O)c2ccccn2)c1)NC1CCCCC1,CHEMBL4433204,=,=,IC50,nM,2630.0,IC50,uM,2.63,O=C(Nc1cccc(NC(=O)c2ccccn2)c1)NC1CCCCC1,2019.0
Inhibition of human MER incubated for 90 mins by ELISA method,O=C(CSC(=S)N1CCCCC1)Nc1cccc(NC(=O)c2ccccn2)c1,CHEMBL4433204,=,=,IC50,nM,3950.0,IC50,uM,3.95,O=C(CSC(=S)N1CCCCC1)Nc1cccc(NC(=O)c2ccccn2)c1,2019.0
Inhibition of human MER incubated for 90 mins by ELISA method,O=C(CCSC(=S)N1CCN(c2ccccc2)CC1)Nc1cccc(NC(=O)c2ccccn2)c1,CHEMBL4433204,=,=,IC50,nM,3120.0,IC50,uM,3.12,O=C(CCSC(=S)N1CCN(c2ccccc2)CC1)Nc1cccc(NC(=O)c2ccccn2)c1,2019.0
Inhibition of N-terminal GST-tagged recombinant human Mer (557 to 882 residues) expressed in baculovirus infected Sf21 cells using GGMEDIYFEFMGGKKK as substrate at 1 uM relative to control,COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1,CHEMBL4477207,=,=,Inhibition,%,56.0,INH,%,56.0,COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1,2016.0
Inhibition of recombinant human GST-tagged MER (578 to 872 residues) expressed in baculovirus expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,CHEMBL4602617,>,>,IC50,nM,100000.0,IC50,uM,100.0,C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C,2020.0
Inhibition of MER (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay,COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC,CHEMBL4602715,>,>,IC50,nM,11000.0,IC50,uM,11.0,COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC,2020.0
Inhibition of MER (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay,COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1,CHEMBL4602715,=,=,IC50,nM,86.0,IC50,uM,0.086,COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1,2020.0
Inhibition of MER (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay,COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC,CHEMBL4602715,>,>,IC50,nM,8700.0,IC50,uM,8.7,COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC,2020.0
Inhibition of recombinant human GST-tagged MER (578 to 872 residues) expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control,CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21,CHEMBL4665648,=,=,Inhibition,%,-4.0,INH,%,-4.0,CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21,2019.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,CHEMBL4673210,>,>,Inhibition,%,80.0,INH,%,80.0,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,2018.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1,CHEMBL4673210,=,=,Activity,%,13.04,Activity,%,13.04,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1,2018.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1,CHEMBL4673210,=,=,Activity,%,75.43,Activity,%,75.43,Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1,2018.0
Inhibition of MER (unknown origin),COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,CHEMBL4680122,>,>,IC50,nM,200.0,IC50,uM,0.2,COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1,2020.0
Inhibition of MER (unknown origin),COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1,CHEMBL4680122,>,>,IC50,nM,200.0,IC50,uM,0.2,COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1,2020.0
Inhibition of MER (unknown origin) at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay relative to control,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,CHEMBL4680210,>,>,Inhibition,%,80.0,INH,%,80.0,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,2020.0
Inhibition of MER (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,CHEMBL4680210,=,=,IC50,nM,16.5,IC50,nM,16.5,CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1,2020.0
Inhibition of human MERTK,COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@@H](C)N(C)[C@@H](C)C1,CHEMBL4699642,=,=,IC50,nM,11.0,IC50,nM,11.0,COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@@H](C)N(C)[C@@H](C)C1,2020.0
Inhibition of recombinant N-terminal GST-tagged human MER (557 to 882 residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,CHEMBL4715694,=,=,Activity,%,24.0,Activity,%,24.0,Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1,2016.0
Inhibition of recombinant N-terminal GST-tagged human MER (557 to 882 residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2,CHEMBL4715694,=,=,Activity,%,1.0,Activity,%,1.0,COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2,2016.0
Inhibition of human c-MER assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control,O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,CHEMBL4715818,=,=,Activity,%,46.53,Activity,%,46.53,O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F,2018.0
Inhibition of human c-MER using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,CHEMBL4715818,=,=,IC50,nM,4.68,IC50,10^-9M,4.68,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,2018.0
Inhibition of wild-type human partial length c-MER (R557 to L884 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control,CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12,CHEMBL4715821,=,=,Activity,%,97.02,Activity,%,97.02,CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12,2018.0
Inhibition of MER (unknown origin),CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1,CHEMBL4725315,=,=,IC50,nM,630.96,pIC50,,6.2,CC(C)n1cnnc1-c1cccc(N2Cc3ccccc3C2=O)n1,2020.0
Inhibition of MER (unknown origin),CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1,CHEMBL4725315,<,>,IC50,nM,19952.62,pIC50,,4.7,CC(C)n1cnnc1-c1cccc(NC(=O)C2CCCCO2)n1,2020.0
Inhibition of recombinant human MER (557 to 882 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control,CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1,CHEMBL4765237,=,=,Activity,%,0.0,Activity,%,0.0,CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1,2018.0
Inhibition of recombinant human MER (557 to 882 residues) using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay,CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1,CHEMBL4765237,=,=,IC50,nM,1493.0,IC50,uM,1.493,CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1,2018.0
Inhibition of human MER at 100 nM in presence of ATP relative to control,Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1,CHEMBL4765285,=,=,Inhibition,%,100.0,INH,%,100.0,Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1,2020.0
Inhibition of human MER in presence of ATP,Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1,CHEMBL4765285,=,=,IC50,nM,3.01,IC50,nM,3.01,Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1,2020.0
Inhibition of MER in human NCI-H929 cells by mass spectroscopic analysis,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,CHEMBL4804281,=,=,% inhibition,uM,-2.0,% inhibition,uM,-2.0,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,2020.0
Inhibition of MER in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,-11.0,% inhibition,uM,-11.0,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of MER in human NCI-H929 cells by mass spectroscopic analysis,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,% inhibition,uM,4.6,% inhibition,uM,4.6,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of MER in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1,2020.0
Inhibition of MER in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of MER in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,CHEMBL4804281,=,=,Inhibition,%,0.0,INH,%,0.0,Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O,2020.0
Inhibition of human MERTK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,CHEMBL4804282,=,=,Activity,%,89.0,Activity,%,89.0,CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1,2020.0
Inhibition of human MERTK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control,COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F,CHEMBL4804283,=,=,Activity,%,70.0,Activity,%,70.0,COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F,2020.0
Inhibition of DNA-tagged human MERTK assessed as percent of control at 50000 nM by qPCR analysis relative to control,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,CHEMBL4804284,=,=,Activity,%,100.0,Activity,%,100.0,CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21,2020.0
Inhibition of human MERTK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Activity,%,89.0,Activity,%,89.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of human MERTK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,CHEMBL4804286,=,=,Activity,%,100.0,Activity,%,100.0,CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1,2020.0
Inhibition of MERTK (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2020.0
Inhibition of MERTK (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1,2020.0
Inhibition of MERTK (unknown origin) assessed as residual activity measured at 1 uM,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,CHEMBL4806967,>,>,Activity,%,75.0,Activity,%,75.0,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1,2020.0
Inhibition of MER (unknown origin) at 0.5 uM relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1,CHEMBL4806968,=,=,Inhibition,%,91.0,INH,%,91.0,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1,2020.0
Inhibition of MER (unknown origin) at 0.5 uM relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1,CHEMBL4806968,=,=,Inhibition,%,55.0,INH,%,55.0,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1,2020.0
Inhibition of MER (unknown origin) at 0.5 uM relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1,CHEMBL4806968,=,=,Inhibition,%,60.0,INH,%,60.0,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1,2020.0
Inhibition of MER (unknown origin) at 0.5 uM relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1,CHEMBL4806968,=,=,Inhibition,%,49.0,INH,%,49.0,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1,2020.0
Inhibition of MER (unknown origin) at 0.5 uM relative to control,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1,CHEMBL4806968,=,=,Inhibition,%,41.0,INH,%,41.0,CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1,2020.0
